KR101852926B1 - An electroluminescent compound and an electroluminescent device comprising the same - Google Patents

An electroluminescent compound and an electroluminescent device comprising the same Download PDF

Info

Publication number
KR101852926B1
KR101852926B1 KR1020140192183A KR20140192183A KR101852926B1 KR 101852926 B1 KR101852926 B1 KR 101852926B1 KR 1020140192183 A KR1020140192183 A KR 1020140192183A KR 20140192183 A KR20140192183 A KR 20140192183A KR 101852926 B1 KR101852926 B1 KR 101852926B1
Authority
KR
South Korea
Prior art keywords
group
layer
mol
compound
substituted
Prior art date
Application number
KR1020140192183A
Other languages
Korean (ko)
Other versions
KR20160080420A (en
Inventor
현서용
정성욱
김동원
Original Assignee
(주)피엔에이치테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)피엔에이치테크 filed Critical (주)피엔에이치테크
Priority to KR1020140192183A priority Critical patent/KR101852926B1/en
Publication of KR20160080420A publication Critical patent/KR20160080420A/en
Application granted granted Critical
Publication of KR101852926B1 publication Critical patent/KR101852926B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/02Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S428/00Stock material or miscellaneous articles
    • Y10S428/917Electroluminescent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 유기전계발광소자에 채용되는 유기발광 화합물에 관한 것으로서, 하기 [화학식 1]로 표시되는 것을 특징으로 하고, 이를 발광층 내의 도판트 화합물 또는 정공수송 화합물로 채용하는 경우 구동전압, 휘도 및 장수명 등의 발광특성이 우수한 유기전계발광소자를 구현할 수 있다.
[화학식 1]

Figure 112014127180143-pat00299
The present invention relates to an organic electroluminescent compound used in an organic electroluminescent device, and is characterized by being represented by the following formula (1). When this compound is employed as a dopant compound or a hole transport compound in a light emitting layer, The organic electroluminescent device having excellent light emission characteristics can be realized.
[Chemical Formula 1]
Figure 112014127180143-pat00299

Description

유기발광 화합물 및 이를 포함하는 유기전계발광소자{An electroluminescent compound and an electroluminescent device comprising the same}TECHNICAL FIELD The present invention relates to an organic electroluminescent compound and an electroluminescent device comprising the same,

본 발명은 유기발광 화합물에 관한 것으로서, 보다 구체적으로는 유기전계발광소자의 발광층의 도판트 화합물 또는 정공수송 기능층의 정공수송 화합물로 채용되는 유기발광 화합물 및 이를 채용하여 장수명 및 발광 효율 등의 발광 특성이 현저히 향상된 유기전계발광소자에 관한 것이다.The present invention relates to an organic light emitting compound, and more specifically, to an organic light emitting compound which is employed as a dopant compound of a light emitting layer of a light emitting layer of an organic electroluminescent device or a hole transporting compound of a hole transporting functional layer, To an organic electroluminescent device with remarkably improved characteristics.

유기발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기발광 현상을 이용하는 유기전계발광소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기전계발광소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등으로 이루어질 수 있다. 이러한 유기전계발광소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기전계발광소자는 자발광, 고휘도, 고효율, 낮은 구동 전압, 넓은 시야각, 높은 콘트라스트, 고속 응답성 등의 특성을 갖는 것으로 알려져 있다.An organic light emitting phenomenon is a phenomenon that converts electric energy into light energy by using an organic material. An organic electroluminescent device using an organic light emitting phenomenon usually has a structure including an anode, an anode, and an organic material layer therebetween. Here, in order to enhance the efficiency and stability of the organic electroluminescent device, the organic material layer may have a multi-layer structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic electroluminescent device, holes are injected into the anode, electrons are injected into the organic layer from the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out. Such an organic electroluminescent device is known to have properties such as self-emission, high luminance, high efficiency, low driving voltage, wide viewing angle, high contrast, and high speed response.

유기전계발광소자에서 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질과 전하 수송 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. 또한, 발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다.Materials used as an organic material layer in an organic electroluminescent device can be classified into a light emitting material and a charge transporting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions. In addition, the luminescent material can be classified into blue, green and red luminescent materials and yellow and orange luminescent materials necessary for realizing a better natural color depending on the luminescent color.

한편, 발광 물질로서 하나의 물질만 사용하는 경우 분자간 상호 작용에 의하여 최대 발광 파장이 장파장으로 이동하고 색순도가 떨어지거나 발광 감쇄 효과로 소자의 효율이 감소되는 문제가 발생하므로, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.On the other hand, when only one material is used as the light emitting material, there arises a problem that the maximum light emitting wavelength shifts to a long wavelength due to intermolecular interaction, the color purity drops, or the efficiency of the device decreases due to the light emission attenuating effect. A host / dopant system may be used as a light emitting material in order to increase the efficiency of light emission through the light emitting layer.

유기전계발광소자가 전술한 우수한 특징들을 충분히 발휘하기 위해서는 소자 내 유기물층을 이루는 물질, 예컨대 정공 주입 물질, 정공 수송 물질, 발광 물질, 전자 수송 물질, 전자 주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되는 것이 선행되어야 하나, 아직까지 안정하고 효율적인 유기 발광 소자용 유기물층 재료의 개발이 충분히 이루어지지 않은 상태이다. 따라서 새로운 재료의 개발이 계속 요구되고 있으며, 이와 같은 재료 개발의 필요성은 전술한 다른 유기 전자 소자에서도 마찬가지이다.In order for the organic electroluminescent device to sufficiently exhibit the above-described excellent characteristics, materials constituting the organic material layer in the device, such as a hole injecting material, a hole transporting material, a light emitting material, an electron transporting material, and an electron injecting material are supported by a stable and efficient material However, the development of stable and efficient organic material layer materials for organic light emitting devices has not yet been sufficiently developed. Therefore, development of new materials is continuously required, and the necessity of developing such materials is the same in other organic electronic devices described above.

청색발광물질로서 미국 등록특허 제US7053255에는 중심부는 디페닐안트라센 구조를 가지며, 아릴기가 말단에 치환된 청색 발광 화합물 및 이를 이용한 유기전계발광소자가 개시되어 있지만 발광효율 및 휘도가 충분하지 않다는 문제점이 있다. 한편, 미국등록특허공보 제US7233019호, 대한민국공개특허공보 제2006-0006760호에는 치환된 피렌계 화합물을 이용한 유기전계발광소자가 개시되어 있으나, 청색의 색순도가 낮아서 진한 청색(deep blue)의 구현이 어렵기 때문에 천연색의 풀컬러 디스플레이를 구현하는데 문제점이 있다.As a blue light emitting material, US Pat. No. 7053255 discloses a blue light emitting compound having a diphenyl anthracene structure and an aryl group substituted at the terminal thereof, and an organic electroluminescent device using the blue light emitting compound, but has a problem in that the light emitting efficiency and brightness are not sufficient . On the other hand, US Pat. No. 7,230,019 and Korean Patent Laid-Open Publication No. 2006-0006760 disclose an organic electroluminescent device using a substituted pyrene compound. However, since the blue color purity is low, It is difficult to implement a full color full color display.

본 발명은 유기전계발광소자의 발광층의 도판트 화합물 또는 정공수송 기능층의 정공수송 화합물로 채용되어 우수한 발광 특성을 구현할 수 있는 신규한 유기발광 화합물 및 이를 포함하는 유기전계발광 소자를 제공하고자 한다.The present invention is to provide a novel organic light emitting compound and an organic electroluminescent device including the organic light emitting compound which can be used as a dopant compound or a hole transporting compound of a hole transporting functional layer in a light emitting layer of an organic electroluminescent device to realize excellent light emitting characteristics.

본 발명은 상기 과제를 해결하기 위하여, 하기 [화학식 1]로 표시되는 것을 특징으로 하는 유기발광 화합물 및 이를 포함하는 유기전계발광소자를 제공한다.In order to solve the above-described problems, the present invention provides an organic light-emitting compound represented by the following Chemical Formula 1 and an organic electroluminescent device including the same.

[화학식 1][Chemical Formula 1]

Figure 112014127180143-pat00001
Figure 112014127180143-pat00001

상기 [화학식 1]에 따른 유기발광 화합물의 구체적인 구조 및 치환기에 대해서는 후술한다.The specific structure and substituent of the organic luminescent compound according to the formula 1 will be described later.

본 발명에 따른 유기발광 화합물을 발광층의 도판트 화합물 또는 정공수송 기능층의 정공수송 화합물로 채용한 유기전계발광소자는 보다 향상된 발광 효율과 장수명 특성의 구현이 가능하여 이를 채용한 유기전계발광소자는 다양한 디스플레이 소자에 유용하여 사용될 수 있다.The organic electroluminescent device employing the organic electroluminescent compound according to the present invention as a dopant compound of a light emitting layer or a hole transporting compound of a hole transporting layer can realize a further improved luminous efficiency and long life characteristics, And can be used for various display devices.

도 1 내지 5는 본 발명의 일 실시예에 따른 유기전계발광소자의 구조를 예시한 단면도이다.
도 6은 본 발명에 따른 유기발광 화합물의 구조를 나타낸 대표도이다.
1 to 5 are cross-sectional views illustrating the structure of an organic electroluminescent device according to an embodiment of the present invention.
6 is a schematic diagram showing the structure of an organic luminescent compound according to the present invention.

이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.

본 발명은 하기 [화학식 1]로 표시되는 신규한 유기발광 화합물에 관한 것이다.The present invention relates to a novel organic luminescent compound represented by the following formula (1).

[화학식 1][Chemical Formula 1]

Figure 112014127180143-pat00002
Figure 112014127180143-pat00002

상기 [화학식 1]에서,In the above formula (1)

X는 R1-C-R2이고, 상기 R1 및 R2는 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 24의 알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기 중에서 선택되고, 바람직하게는 메틸기 또는 페닐기이다.X is R 1 -CR 2 , each of R 1 and R 2 independently represents a substituted or unsubstituted alkyl group having 1 to 24 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, and a substituted or unsubstituted carbon number 3 to 50 heteroaryl groups, preferably a methyl group or a phenyl group.

Ar1 내지 Ar4는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택된다.Ar 1 to Ar 4 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted group having 5 to 50 carbon atoms A substituted or unsubstituted aryl group, a substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl substituted or unsubstituted aryl group having 5 to 50 carbon atoms, And a substituted or unsubstituted C2 to C50 heteroaryl group in which one or more ring-opened cycloalkyl having 3 to 30 carbon atoms is fused.

또한, 상기 Ar1 및 Ar2와 Ar3 및 Ar4는 각각 서로 결합하거나 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.Ar 1 , Ar 2 , Ar 3 and Ar 4 may be bonded to each other or may be connected to adjacent substituents to form a single alicyclic or aromatic ring or a polycyclic ring, and the alicyclic group, The carbon atom of the polycyclic ring may be substituted with any one or more heteroatoms selected from N, S and O.

A는 하기 [구조식 1] 또는 [구조식 2]로 표시되는 것을 특징으로 하는 치환기이다.A is a substituent that is represented by the following structural formula 1 or structural formula 2:

[구조식 1][Structural formula 1]

Figure 112014127180143-pat00003
Figure 112014127180143-pat00003

[구조식 2][Structural formula 2]

Figure 112014127180143-pat00004
Figure 112014127180143-pat00004

상기 [구조식 1] 또는 [구조식 2]에서,In the structural formula 1 or the structural formula 2,

L은 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬렌기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴렌기 중에서 선택되고, n은 0 내지 4의 정수이며, 상기 n이 2 이상인 경우, 복수 개의 L1은 서로 동일하거나 상이할 수 있다.L is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted group having 2 to 30 carbon atoms A substituted or unsubstituted C2-C30 alkynylene group, a substituted or unsubstituted C3-C30 A substituted or unsubstituted C2 to C30 heteroarylene group, a substituted or unsubstituted C3 to C30 cycloalkyl, a substituted or unsubstituted C1 to C50 arylene group, a substituted or unsubstituted C2 to C30 heteroarylene group, A substituted or unsubstituted C2 to C50 heteroarylene group in which at least one unsubstituted C1 to C50 arylene group and substituted or unsubstituted C3 to C30 cycloalkyl are fused together and n is 0 to 4 And when n is 2 or more, a plurality of L < 1 > may be the same or different from each other.

Ar5 내지 Ar7은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택된다.Ar 5 to Ar 7 are the same or different and each independently represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted group having 5 to 50 carbon atoms A substituted or unsubstituted aryl group, a substituted or unsubstituted C2 to C50 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl substituted or unsubstituted aryl group having 5 to 50 carbon atoms, And a substituted or unsubstituted C2 to C50 heteroaryl group in which at least one of the ring-opened cycloalkyls having 3 to 30 carbon atoms is fused.

또한, 상기 Ar5 및 Ar6는 서로 결합하거나 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있다.Ar 5 and Ar 6 may be bonded to each other or may be connected to adjacent substituents to form a single alicyclic or aromatic ring or polycyclic ring. The carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may be N, S and < RTI ID = 0.0 > O, < / RTI >

또한, p는 0 내지 3이 정수이고, 상기 p가 2 이상인 경우 복수의 *-( )는 서로 동일하거나 상이할 수 있다.
P is an integer of 0 to 3, and when p is 2 or more, a plurality of * - () may be the same or different from each other.

한편, 상기 R1, R2, L 및 Ar1 내지 Ar7은 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 수소, 중수소, 시아노기, 할로겐기, 아미노기, 니트로기, 히드록시기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택될 수 있다.
R 1 , R 2 , L and Ar 1 to Ar 7 may be further substituted with one or more substituents, and the at least one substituent may be hydrogen, deuterium, cyano, halogen, amino, nitro, , A halogenated alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 50 carbon atoms, Group, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, an alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, A substituted or unsubstituted aryl group having 5 to 50 carbon atoms which is substituted or unsubstituted and at least one substituted or unsubstituted cycloalkyl having 3 to 30 carbon atoms is fused, and a substituted or unsubstituted cycloalkyl having 3 to 30 carbon atoms It fused one or more substituted or may be selected from heteroaryl unsubstituted C2 to 50 groups.

본 발명에 있어서, 상기 치환기들의 예시들에 대해서 아래에서 구체적으로 설명하나, 이에 한정되는 것은 아니다.In the present invention, examples of the substituents will be specifically described below, but the present invention is not limited thereto.

본 발명에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하다. 구체적인 예로는 메틸기, 에틸기, 프로필기, n-프로필기, 이소프로필기, 부틸기, n-부틸기, 이소부틸기, tert-부틸기, sec-부틸기, 1-메틸-부틸기, 1-에틸-부틸기, 펜틸기, n-펜틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, 헥실기, n-헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 4-메틸-2-펜틸기, 3,3-디메틸부틸기, 2-에틸부틸기, 헵틸기, n-헵틸기, 1-메틸헥실기, 시클로펜틸메틸기, 시클로헥틸메틸기, 옥틸기, n-옥틸기, tert-옥틸기, 1-메틸헵틸기, 2-에틸헥실기, 2-프로필펜틸기, n-노닐기, 2,2-디메틸헵틸기, 1-에틸-프로필기, 1,1-디메틸-프로필기, 이소헥실기, 2-메틸펜틸기, 4-메틸헥실기, 5-메틸헥실기 등이 있으나, 이들에 한정되지 않는다.In the present invention, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, Ethyl, propyl, isopropyl, n-butyl, isobutyl, isobutyl, isobutyl, A tert-butyl group, a tert-butyl group, a 2-pentyl group, a 3,3-dimethylbutyl group, a 2-ethylbutyl group, a heptyl group, Ethylhexyl group, 2-propylpentyl group, n-nonyl group, 2,2-dimethylheptyl group, 1-ethyl-propyl group, 1,1-dimethyl-propyl group , Isohexyl group, 2-methylpentyl group, 4-methylhexyl group, 5-methylhexyl group and the like, but are not limited thereto.

본 발명에 있어서, 알콕시기는 직쇄 또는 분지쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 입체적 방해를 주지 않는 범위인 1 내지 30개인 것이 바람직하다. 구체적으로, 메톡시기, 에톡시기, n-프로폭시기, 이소프로폭시기, i-프로필옥시기, n-부톡시기, 이소부톡시기, tert-부톡시기, sec-부톡시기, n-펜틸옥시기, 네오펜틸옥시기, 이소펜틸옥시기, n-헥실옥시기, 3,3-디메틸부틸옥시기, 2-에틸부틸옥시기, n-옥틸옥시기, n-노닐옥시기, n-데실옥시기, 벤질옥시기, p-메틸벤질옥시기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the alkoxy group may be linear or branched. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably in the range of 1 to 30, which does not cause steric hindrance. Specific examples thereof include a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an i-propyloxy group, a n-butoxy group, an isobutoxy group, a tert- , Neopentyloxy group, isopentyloxy group, n-hexyloxy group, 3,3-dimethylbutyloxy group, 2-ethylbutyloxy group, n-octyloxy group, n- , A benzyloxy group, a p-methylbenzyloxy group, and the like, but are not limited thereto.

본 발명에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 구체적인 예로는 비닐기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 3-메틸-1-부테닐기, 1,3-부타디에닐기, 알릴기, 1-페닐비닐-1-일기, 2-페닐비닐-1-일기, 2,2-디페닐비닐-1-일기, 2-페닐-2-(나프틸-1-일)비닐-1-일기, 2,2-비스(디페닐-1-일)비닐-1-일기, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present invention, the alkenyl group may be straight-chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. Specific examples include a vinyl group, a 1-propenyl group, an isopropenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-pentenyl group, a 2-pentenyl group, a 3-pentenyl group, 2-phenylvinyl-1-yl group, 2,2-diphenylvinyl-1-yl group, 2-phenyl-2-yl group, But are not limited to, - (naphthyl-1-yl) vinyl-1-yl group, 2,2-bis (diphenyl-1-yl) vinyl-1-yl group, stilbenyl group, styrenyl group and the like.

본 발명에 있어서, 아릴기는 단환식 또는 다환식일 수 있고, 탄소수는 특별히 한정되지 않으나 6 내지 60인 것이 바람직하다. 단환식 아릴기의 예로는 페닐기, 비페닐기, 터페닐기, 스틸벤기 등이 있고, 다환식 아릴기의 예로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 테트라세닐기, 크라이세닐기, 플루오레닐기, 아세나프타센닐기, 트리페닐렌기, 플루오안트렌(fluoranthrene)기 등이 있으나, 본 발명의 범위가 이들 예로만 한정되는 것은 아니다.In the present invention, the aryl group may be monocyclic or polycyclic, and the number of carbon atoms is not particularly limited, but is preferably 6 to 60. [ Examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group and a stilbene group. Examples of the polycyclic aryl group include a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, , A chlorenyl group, a fluorenyl group, an acenaphthacenyl group, a triphenylene group, and a fluororanthrene group, but the scope of the present invention is not limited to these examples.

본 발명에 있어서, 헤테로고리기는 이종원자로 O, N 또는 S를 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 트리아졸기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 디벤조퓨라닐기, 페난트롤린기, 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기, 티아디아졸릴기, 벤조티아졸릴기, 페노티아지닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present invention, the heterocyclic group is a heterocyclic group containing O, N or S as a heteroatom, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furane group, a furyl group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, A pyridazinyl group, a pyrazinopyrazinyl group, an isoquinoline group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolyl group, , An indole group, a carbazole group, a benzoxazole group, a benzoimidazole group, a benzothiazole group, a benzocarbazole group, a benzothiophene group, a dibenzothiophene group, a benzofuranyl group, a dibenzofurancyl group, a phenanthroline group, An isothiazolyl group, an isoxazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzothiazolyl group, a phenothiazinyl group and the like, but is not limited thereto.

본 발명에 있어서, 아릴옥시기, 아릴티옥시기, 아릴술폭시기 및 아랄킬아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 구체적으로 아릴옥시기로는 페녹시기, p-토릴옥시기, m-토릴옥시기, 3,5-디메틸-페녹시기, 2,4,6-트리메틸페녹시기, ptert-부틸페녹시기, 3-비페닐옥시기, 4-비페닐옥시기, 1-나프틸옥시기, 2-나프틸옥시기, 4-메틸-1-나프틸옥시기, 5-메틸-2-나프틸옥시기, 1-안트릴옥시기, 2-안트릴옥시기, 9-안트릴옥시기, 1-페난트릴옥시기, 3-페난트릴옥시기, 9-페난트릴옥시기 등이 있고, 아릴티옥시기로는 페닐티옥시기기, 2-메틸페닐티옥시기, 4-tert-부틸페닐티옥시기 등이 있으며, 아릴술폭시기로는 벤젠술폭시기, p-톨루엔술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the aryl group in the aryloxy group, arylthioxy group, arylsulfoxy group and aralkylamine group is the same as the aforementioned aryl group. Specific examples of the aryloxy group include a phenoxy group, a p-tolyloxy group, an m-tolyloxy group, a 3,5-dimethyl-phenoxy group, a 2,4,6-trimethylphenoxy group, a ptert- Anthryloxy group, 2-naphthyloxy group, 2-naphthyloxy group, 4-methyl-1-naphthyloxy group, Anthryloxy group, 9-anthryloxy group, 1-phenanthryloxy group, 3-phenanthryloxy group, 9-phenanthryloxy group and the like. Examples of the arylthioxy group include phenylthioxy group, 2- A 4-tert-butylphenyloxy group, and the like. Examples of the arylsulfoxy group include benzene sulfoxy group and p-toluenesulfoxy group. However, the present invention is not limited thereto.

본 발명에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 구체적으로 시클로프로필기 시클로부틸기 시클로펜틸기 3-메틸시클로펜틸기 2,3-디메틸시클로펜틸기, 시클로헥실기, 3-메틸시클로헥실기, 4-메틸시클로헥실기, 2,3-디메틸시클로헥실기, 3,4,5-트리메틸시클로헥실기, 4-tert-부틸시클로헥실기, 시클로헵틸기, 시클로옥틸기 등이 있으나, 이에 한정되지 않는다.In the present invention, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and specifically includes cyclopropyl group, cyclobutyl group, cyclopentyl group, 3-methylcyclopentyl group, 2,3-dimethylcyclopentyl group, Methylcyclohexyl group, 2,3-dimethylcyclohexyl group, 3,4,5-trimethylcyclohexyl group, 4-tert-butylcyclohexyl group, cycloheptyl group, cyclo An octyl group, and the like, but are not limited thereto.

본 발명에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In the present invention, examples of the halogen group include fluorine, chlorine, bromine or iodine.

본 발명에 있어서, 아릴아민기의 예로는 치환 또는 비치환된 모노아릴아민기, 치환 또는 비치환된 디아릴아민기, 또는 치환 또는 비치환된 트리아릴아민기가 있다. 상기 아릴아민기 중의 아릴기는 단환식 아릴기일 수 있고, 다환식 아릴기일 수 있다. 상기 아릴기가 2 이상을 포함하는 아릴아민기는 단환식 아릴기, 다환식 아릴기, 또는 단환식아릴기와 다환식 아릴기를 동시에 포함할 수 있다.In the present invention, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group having at least two aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or a monocyclic aryl group and a polycyclic aryl group at the same time.

상기 아릴아민기의 구체적인 예로는 페닐아민기, 나프틸아민기, 비페닐아민기, 안트라세닐아민기, 3-메틸-페닐아민기, 4-메틸-나프틸아민기, 2-메틸-비페닐아민기, 9-메틸-안트라세닐아민기, 디페닐 아민기, 페닐 나프틸 아민기, 디톨릴 아민기, 페닐 톨릴 아민기, 카바졸기 및 트리페닐 아민기 등이 있으나, 이에 한정되는 것은 아니다.Specific examples of the arylamine group include a phenylamine group, a naphthylamine group, a biphenylamine group, an anthracenylamine group, a 3-methylphenylamine group, a 4-methylnaphthylamine group, But are not limited to, an amine group, a 9-methyl-anthracenylamine group, a diphenylamine group, a phenylnaphthylamine group, a ditolylamine group, a phenyltolylamine group, a carbazole group and a triphenylamine group.

본 발명에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다.In the present invention, the silyl group is specifically exemplified by trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, But are not limited thereto.

본 발명에 있어서, 헤테로아릴아민기 중의 헤테로 아릴기는 전술한 헤테로고리기의 예시 중에서 선택될 수 있다.In the present invention, the heteroaryl group in the heteroarylamine group can be selected from the examples of the above-mentioned heterocyclic group.

본 발명에 있어서, 알킬티옥시기, 알킬술폭시기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기, 에틸티옥시기, tert-부틸티옥시기, 헥실티옥시기, 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실, 에틸술폭시기, 프로필술폭시기, 부틸술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the alkyloxy group in the alkylthio group and the alkyl group in the alkylsulfoxy group are the same as the aforementioned alkyl groups. Specific examples of the alkyloxy group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group and an octylthio group. Examples of the alkylsulfoxy group include a mesyl group, an ethylsulfoxy group, a propylsulfoxy group, But are not limited thereto.

본 발명에 있어서, 치환된 아릴렌기라 함은, 페닐기, 비페닐기, 나프탈렌기, 플루오레닐기, 파이레닐기, 페난트레닐기, 페릴렌기, 테트라세닐기. 안트라센닐기 등이 다른 치환기로 치환된 것을 의미한다.In the present invention, the substituted arylene group means a phenyl group, a biphenyl group, a naphthalene group, a fluorenyl group, a pyrenyl group, a phenanthrenyl group, a perylene group, a tetracenyl group. Anthracenyl group and the like are substituted with other substituents.

본 발명에 있어서, 치환된 헤테로아릴렌기라 함은, 피리딜기, 티오페닐기, 트리아진기, 퀴놀린기, 페난트롤린기, 이미다졸기, 티아졸기, 옥사졸기, 카바졸기 및 이들의 축합헤테로고리기, 예컨대 벤즈퀴놀린기, 벤즈이미다졸기, 벤즈옥사졸기, 벤즈티아졸기, 벤즈카바졸기, 디벤조티오페닐기, 디벤조퓨란기 등이 다른 치환기로 치환된 것을 의미한다.
In the present invention, the substituted heteroarylene group includes a pyridyl group, a thiophenyl group, a triazine group, a quinoline group, a phenanthroline group, an imidazole group, a thiazole group, an oxazole group, a carbazole group and condensed heterocyclic groups, Such as a benzoquinoline group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzzcarbazole group, a dibenzothiophenyl group, a dibenzofurane group and the like are substituted with other substituents.

상기 [화학식 1]로 표시되는 본 발명에 따른 유기발광 화합물은 그 구조적 특이성으로 인하여 유기전계발광소자의 다양한 유기물층에 사용될 수 있고, 바람직하게는 발광층 내의 도판트 화합물 또는 정공수송층의 정공수송 화합물로 사용될 수 있다.The organic electroluminescent compound according to the present invention represented by the above formula (1) can be used in various organic layers of organic electroluminescent devices due to its structural specificity, and is preferably used as a hole transport compound in a dopant compound or a hole transport layer in a light emitting layer .

본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물의 구체적인 예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Specific examples of the organic luminescent compound represented by formula (1) according to the present invention include, but are not limited to, the following compounds.

Figure 112014127180143-pat00005
Figure 112014127180143-pat00005

Figure 112014127180143-pat00006
Figure 112014127180143-pat00006

Figure 112014127180143-pat00007
Figure 112014127180143-pat00007

Figure 112014127180143-pat00008
Figure 112014127180143-pat00008

Figure 112014127180143-pat00009
Figure 112014127180143-pat00009

Figure 112014127180143-pat00010
Figure 112014127180143-pat00010

Figure 112014127180143-pat00011
Figure 112014127180143-pat00011

Figure 112014127180143-pat00012
Figure 112014127180143-pat00012

Figure 112014127180143-pat00013
Figure 112014127180143-pat00013

Figure 112014127180143-pat00014
Figure 112014127180143-pat00014

Figure 112014127180143-pat00015
Figure 112014127180143-pat00015

Figure 112014127180143-pat00016
Figure 112014127180143-pat00016

Figure 112014127180143-pat00017
Figure 112014127180143-pat00017

Figure 112014127180143-pat00018
Figure 112014127180143-pat00018

Figure 112014127180143-pat00019
Figure 112014127180143-pat00019

Figure 112014127180143-pat00020
Figure 112014127180143-pat00020

Figure 112014127180143-pat00021
Figure 112014127180143-pat00021

Figure 112014127180143-pat00022
Figure 112014127180143-pat00022

Figure 112014127180143-pat00023
Figure 112014127180143-pat00023

Figure 112014127180143-pat00024
Figure 112014127180143-pat00024

Figure 112014127180143-pat00025
Figure 112014127180143-pat00025

Figure 112014127180143-pat00026
Figure 112014127180143-pat00026

Figure 112014127180143-pat00027
Figure 112014127180143-pat00027

Figure 112014127180143-pat00028
Figure 112014127180143-pat00028

Figure 112014127180143-pat00029
Figure 112014127180143-pat00029

Figure 112014127180143-pat00030
Figure 112014127180143-pat00030

Figure 112014127180143-pat00031
Figure 112014127180143-pat00031

Figure 112014127180143-pat00032
Figure 112014127180143-pat00032

Figure 112014127180143-pat00033
Figure 112014127180143-pat00033

Figure 112014127180143-pat00034
Figure 112014127180143-pat00034

Figure 112014127180143-pat00035
Figure 112014127180143-pat00035

Figure 112014127180143-pat00036
Figure 112014127180143-pat00036

Figure 112014127180143-pat00037
Figure 112014127180143-pat00037

Figure 112014127180143-pat00038
Figure 112014127180143-pat00038

Figure 112014127180143-pat00039
Figure 112014127180143-pat00039

Figure 112014127180143-pat00040
Figure 112014127180143-pat00040

Figure 112014127180143-pat00041
Figure 112014127180143-pat00041

Figure 112014127180143-pat00042
Figure 112014127180143-pat00042

Figure 112014127180143-pat00043
Figure 112014127180143-pat00043

Figure 112014127180143-pat00044
Figure 112014127180143-pat00044

Figure 112014127180143-pat00045
Figure 112014127180143-pat00045

Figure 112014127180143-pat00046
Figure 112014127180143-pat00046

Figure 112014127180143-pat00047
Figure 112014127180143-pat00047

Figure 112014127180143-pat00048
Figure 112014127180143-pat00048

Figure 112014127180143-pat00049
Figure 112014127180143-pat00049

Figure 112014127180143-pat00050
Figure 112014127180143-pat00050

Figure 112014127180143-pat00051
Figure 112014127180143-pat00051

Figure 112014127180143-pat00052
Figure 112014127180143-pat00052

Figure 112014127180143-pat00053
Figure 112014127180143-pat00053

Figure 112014127180143-pat00054
Figure 112014127180143-pat00054

Figure 112014127180143-pat00055
Figure 112014127180143-pat00055

Figure 112014127180143-pat00056
Figure 112014127180143-pat00056

Figure 112014127180143-pat00057
Figure 112014127180143-pat00057

Figure 112014127180143-pat00058
Figure 112014127180143-pat00058

Figure 112014127180143-pat00059
Figure 112014127180143-pat00059

Figure 112014127180143-pat00060
Figure 112014127180143-pat00060

Figure 112014127180143-pat00061
Figure 112014127180143-pat00061

Figure 112014127180143-pat00063
Figure 112014127180143-pat00063

Figure 112014127180143-pat00064
Figure 112014127180143-pat00064

Figure 112014127180143-pat00065
Figure 112014127180143-pat00065

Figure 112014127180143-pat00066
Figure 112014127180143-pat00066

Figure 112014127180143-pat00067
Figure 112014127180143-pat00067

Figure 112014127180143-pat00068
Figure 112014127180143-pat00068

Figure 112014127180143-pat00069
Figure 112014127180143-pat00069

Figure 112014127180143-pat00070
Figure 112014127180143-pat00070

Figure 112014127180143-pat00071
Figure 112014127180143-pat00071

Figure 112014127180143-pat00072
Figure 112014127180143-pat00072

Figure 112014127180143-pat00073
Figure 112014127180143-pat00073

Figure 112014127180143-pat00074
Figure 112014127180143-pat00074

Figure 112014127180143-pat00075
Figure 112014127180143-pat00075

Figure 112014127180143-pat00076
Figure 112014127180143-pat00076

Figure 112014127180143-pat00077
Figure 112014127180143-pat00077

Figure 112014127180143-pat00078
Figure 112014127180143-pat00078

Figure 112014127180143-pat00079
Figure 112014127180143-pat00079

Figure 112014127180143-pat00080
Figure 112014127180143-pat00080

Figure 112014127180143-pat00081
Figure 112014127180143-pat00081

Figure 112014127180143-pat00082
Figure 112014127180143-pat00082

Figure 112014127180143-pat00083
Figure 112014127180143-pat00083

Figure 112014127180143-pat00084
Figure 112014127180143-pat00084

Figure 112014127180143-pat00085
Figure 112014127180143-pat00085

Figure 112014127180143-pat00086
Figure 112014127180143-pat00086

Figure 112014127180143-pat00087
Figure 112014127180143-pat00087

Figure 112014127180143-pat00088
Figure 112014127180143-pat00088

Figure 112014127180143-pat00089
Figure 112014127180143-pat00089

Figure 112014127180143-pat00090
Figure 112014127180143-pat00090

Figure 112014127180143-pat00091
Figure 112014127180143-pat00091

Figure 112014127180143-pat00092
Figure 112014127180143-pat00092

Figure 112014127180143-pat00093
Figure 112014127180143-pat00093

Figure 112014127180143-pat00094
Figure 112014127180143-pat00094

Figure 112014127180143-pat00095
Figure 112014127180143-pat00095

Figure 112014127180143-pat00096
Figure 112014127180143-pat00096

Figure 112014127180143-pat00097
Figure 112014127180143-pat00097

Figure 112014127180143-pat00098
Figure 112014127180143-pat00098

Figure 112014127180143-pat00099
Figure 112014127180143-pat00099

Figure 112014127180143-pat00100
Figure 112014127180143-pat00100

Figure 112014127180143-pat00101
Figure 112014127180143-pat00101

Figure 112014127180143-pat00102
Figure 112014127180143-pat00102

Figure 112014127180143-pat00103
Figure 112014127180143-pat00103

Figure 112014127180143-pat00104
Figure 112014127180143-pat00104

Figure 112014127180143-pat00105
Figure 112014127180143-pat00105

Figure 112014127180143-pat00106
Figure 112014127180143-pat00106

Figure 112014127180143-pat00107
Figure 112014127180143-pat00107

Figure 112014127180143-pat00108
Figure 112014127180143-pat00108

Figure 112014127180143-pat00109
Figure 112014127180143-pat00109

Figure 112014127180143-pat00110
Figure 112014127180143-pat00110

Figure 112014127180143-pat00111
Figure 112014127180143-pat00111

Figure 112014127180143-pat00112
Figure 112014127180143-pat00112

Figure 112014127180143-pat00113
Figure 112014127180143-pat00113

Figure 112014127180143-pat00114

Figure 112014127180143-pat00114

상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 유기발광 화합물을 합성할 수 있다. 예컨대, 유기전계발광소자의 제조시 사용되는 정공 주입층 물질, 정공 수송층 물질 및 전자 수송층 물질에 사용되는 치환기를 상기 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 제조할 수 있다.An organic luminescent compound having the intrinsic characteristics of the substituent introduced by introducing various substituents into the core structure having the above structure can be synthesized. For example, a substance that meets the requirements of each organic material layer can be manufactured by introducing a substituent used in a hole injecting layer material, a hole transporting layer material, and an electron transporting layer material used in manufacturing an organic electroluminescent device into the structure.

특히, 본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물은 상기에서 살펴본 바와 같이, 특징적 코어 구조체에 치환기를 도입하여 유기전계발광소자의 발광층에 채용시 효율, 구동전압, 수명 등에서 우수한 특성을 나타내는 유기전계발광소자의 구현이 가능함을 확인하였다.
In particular, the organic electroluminescent compound represented by Formula 1 according to the present invention has excellent characteristics in terms of efficiency at the time of adoption, driving voltage, and life span in a light emitting layer of an organic electroluminescent device by introducing a substituent into the characteristic core structure, It is confirmed that the organic electroluminescent device can be realized.

본 발명의 화합물은 유기전계발광소자의 통상의 제조방법에 따라 소자에 적용할 수 있다. 본 발명의 하나의 실시예에 따른 유기전계발광소자는 제1 전극과 제2 전극 및 이 사이에 배치된 유기물층을 포함하는 구조로 이루어질 수 있으며, 본 발명에 따른 유기발광 화합물을 소자의 유기물층에 사용한다는 것을 제외하고는 통상의 소자의 제조 방법 및 재료를 사용하여 제조될 수 있다.The compound of the present invention can be applied to a device according to a conventional method of manufacturing an organic electroluminescent device. The organic electroluminescent device according to one embodiment of the present invention may have a structure including a first electrode, a second electrode and an organic material layer disposed therebetween, and the organic electroluminescent compound according to the present invention may be used for an organic material layer And can be manufactured using conventional device manufacturing methods and materials.

본 발명에 따른 유기전계발광소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 이에 한정되지 않고 더 적은 수의 유기물층을 포함할 수도 있다.The organic material layer of the organic electroluminescent device according to the present invention may have a single layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer. However, it is not limited to this and may include a smaller number of organic layers.

따라서, 본 발명의 유기전계발광소자에서, 상기 유기물층은 정공 주입층, 정공 수송층, 전자 수송층, 전자 주입층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 주입 및 전자수송을 동시에 하는 층 및 발광층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 화합물을 포함할 수 있으며, 바람직하게는 본 발명에 따른 유기발광 화합물은 발광층 내 도판트 물질 또는 정공수송 기능층의 정공수송 화합물로서 포함될 수 있다.Therefore, in the organic electroluminescent device of the present invention, the organic material layer may be a hole injecting layer, a hole transporting layer, an electron transporting layer, an electron injecting layer, a layer simultaneously injecting and transporting holes, a layer simultaneously performing electron injection and electron transporting, And one or more of the above layers may include a compound represented by the formula 1. Preferably, the organic luminescent compound according to the present invention may include a dopant material or a hole transport material May be included as a hole transporting compound in the functional layer.

상기 [화학식 1]로 표시되는 화합물을 발광층 내 도판트 물질로서 포함되는 경우에, 도판트의 함량은 통상적으로 호스트 약 100 중량부를 기준으로 하여 약 0.01 내지 약 20 중량부의 범위에서 선택될 수 있다. 또한, [화학식 1]로 구현되는 유기발광 화합물 이외에도 호스트 또는 도판트 화합물을 더 포함할 수도 있으며, 그 함량은 상기와 마찬가지이다.
When the compound represented by Formula 1 is included as a dopant in the light emitting layer, the content of the dopant may be generally selected in the range of about 0.01 to about 20 parts by weight based on about 100 parts by weight of the host. In addition to the organic luminescent compound represented by Formula 1, a host or a dopant compound may be further included, and the content thereof is the same as described above.

이와 같은 다층 구조의 유기물층에서 상기 [화학식 1]로 표시되는 화합물은 발광층, 정공 주입/정공 수송과 발광을 동시에 하는 층, 정공 수송과 발광을 동시에 하는 층, 또는 전자 수송과 발광을 동시에 하는 층 등에 포함될 수 있다.In the organic compound layer having such a multilayer structure, the compound represented by the formula (1) may be used in combination with a light emitting layer, a layer that simultaneously transports holes and holes, a layer that simultaneously transports light and emits light, .

예컨대, 본 발명에 따른 유기 전자 소자의 구조는 도 1 내지 5에 예시되어 있다.For example, the structure of an organic electronic device according to the present invention is illustrated in Figs.

도 1에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.1 shows an organic electronic device in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5, an electron transporting layer 6 and a cathode 7 are sequentially laminated on a substrate 1 Structure is illustrated. In this structure, the compound represented by the formula (1) may be included in the hole injection layer (3), the hole transport layer (4), the light emitting layer (5) or the electron transport layer (6).

도 2에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4) 또는 전자 수송층(6)에 포함될 수 있다.2 shows the structure of an organic electronic device in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5 and a cathode 7 are sequentially laminated on a substrate 1. In such a structure, the compound represented by the formula (1) may be included in the hole injection layer (3), the hole transport layer (4), or the electron transport layer (6).

도 3에는 기판(1) 위에 양극(2), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.3 illustrates the structure of an organic electronic device in which an anode 2, a hole transporting layer 4, a light emitting layer 5, an electron transporting layer 6, and a cathode 7 are sequentially stacked on a substrate 1. In such a structure, the compound represented by the formula (1) may be included in the hole transport layer (4), the light emitting layer (5), or the electron transport layer (6).

도 4에는 기판(1) 위에 양극(2), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.4 illustrates the structure of an organic electronic device in which an anode 2, a light emitting layer 5, an electron transport layer 6, and a cathode 7 are sequentially laminated on a substrate 1. In FIG. In such a structure, the compound represented by the formula (1) may be included in the light-emitting layer (5) or the electron-transporting layer (6).

도 5에는 기판(1) 위에 양극(2), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5)에 포함될 수 있다.
5 illustrates the structure of an organic electronic device in which an anode 2, a light-emitting layer 5, and a cathode 7 are sequentially stacked on a substrate 1. As shown in Fig. In such a structure, the compound represented by the formula (1) may be included in the luminescent layer (5).

예컨대, 본 발명에 따른 유기전계발광소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층, 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다.For example, the organic electroluminescent device according to the present invention can be manufactured by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation to form a metal oxide or a conductive metal oxide on the substrate, An anode is formed by depositing an alloy on the anode, and an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, and an electron transporting layer is formed on the anode, and then a substance usable as a cathode is deposited thereon.

이와 같은 방법 외에도, 기판상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기전계발광소자를 만들 수도 있다. 상기 유기물층은 정공 주입층, 정공 수송층, 발광층 및 전자 수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 솔벤트 프로세스(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.In addition to such a method, an organic electroluminescent device may be formed by sequentially depositing a cathode material, an organic material layer, and a cathode material on a substrate. The organic material layer may have a multi-layer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic material layer may be formed using a variety of polymer materials by a solvent process such as a spin coating process, a dip coating process, a doctor blading process, a screen printing process, an inkjet printing process or a thermal transfer process, Layer.

상기 양극 물질로는 통상 유기물층으로 정공주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금, 아연 산화물, 인듐 산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물, ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof, zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO) metal oxides, ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT) , Conductive polymers such as polypyrrole and polyaniline, but are not limited thereto.

상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금, LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or an alloy thereof; a multilayer such as LiF / Al or LiO 2 / Structural materials, and the like, but are not limited thereto.

정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴 헥사아자트리페닐렌, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole injecting material, it is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrine, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene, quinacridone-based organic materials, perylene-based organic materials, Anthraquinone, polyaniline and a polythiophene-based conductive polymer, but are not limited thereto.

정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송 받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole transporting material, a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer and having high mobility to holes is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.

발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3), 카르바졸 계열 화합물, 이량체화 스티릴(dimerized styryl) 화합물, BAlq, 10-히드록시벤조 퀴놀린-금속 화합물, 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물, 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자, 스피로(spiro) 화합물, 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light emitting material is preferably a material capable of emitting light in the visible light region by transporting and combining holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having a high quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ), carbazol-based compounds, dimerized styryl compounds, BAlq, 10-hydroxybenzoquinoline-metal compounds, benzoxazole, benzthiazole and A benzimidazole-based compound, a poly (p-phenylene vinylene) (PPV) -based polymer, a spiro compound, polyfluorene, rubrene, and the like.

전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물, Alq3를 포함한 착물, 유기 라디칼 화합물, 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다.
As the electron transporting material, a material capable of transferring electrons from the cathode well into the light emitting layer, which is highly mobile, is suitable. Specific examples thereof include, but are not limited to, an Al complex of 8-hydroxyquinoline, a complex containing Alq 3 , an organic radical compound, and a hydroxyflavone-metal complex.

본 발명에 따른 유기전계발광소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic electroluminescent device according to the present invention may be a front emission type, a back emission type, or a both-sided emission type, depending on the material used.

또한, 본 발명에 따른 유기발광 화합물은 유기 태양 전지, 유기 감광체, 유기 트랜지스터 등을 비롯한 유기 전자 소자에서도 유기전계발광소자에 적용되는 것과 유사한 원리로 작용할 수 있다.
In addition, the organic electroluminescent compound according to the present invention can act on a principle similar to that applied to an organic electroluminescent device in an organic electronic device including an organic solar cell, an organophotoreceptor, an organic transistor and the like.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나, 하기의 실시예는 본 발명을 예시하기 위한 것이며, 이에 의하여 본 발명의 범위가 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are intended to illustrate the invention and are not intended to limit the scope of the invention.

실시예Example 1 : 화합물 1 합성 1: Synthesis of compound 1

(1) (One) 제조예Manufacturing example 1 : 중간체 1-0의 합성 1: Synthesis of Intermediate 1-0

Figure 112014127180143-pat00115
Figure 112014127180143-pat00115

질소 분위기 하에서 methyl 2-amino-4-chlorobenzoate(1.9 g, 0.010 mol), 1-chloro-3-iodobenzene(2.4 g, 0.010 mol), Pd(dba)3(0.1 g, 0.001 mol),P(t-Bu)3(0.04 g, 0.0002 mol), STBT(2.9 g, 0.030 mol)에 Toluene 70 mL를 넣고 환류 교반하였다. 반응종료 후 H20 : EA에 층분리를 한 후 컬럼정제(N-HEXANE : MC)하여 <중간체 1-0> 1.8 g(수율 62%) 수득하였다. (m/z= 296)
(1.9 g, 0.010 mol), 1-chloro-3-iodobenzene (2.4 g, 0.010 mol), Pd (dba) 3 (0.1 g, 0.001 mol) and P -Bu) 3 (0.04 g, 0.0002 mol) and STBT (2.9 g, 0.030 mol) were added 70 mL of toluene and the mixture was stirred under reflux. After completion of the reaction, the reaction mixture was subjected to layer separation with H 2 O: EA, followed by column purification (N-HEXANE: MC) to obtain <Intermediate 1-0> 1.8 g (yield 62%). (m / z = 296)

(2) (2) 제조예Manufacturing example 2 : 중간체 1-1의 합성 2: Synthesis of intermediate 1-1

Figure 112014127180143-pat00116
Figure 112014127180143-pat00116

중간체 1-0(2.3 g, 0.010 mol)을 넣고 THF 30 mL를 가하여 교반하여 녹인 후, 온도를 0 ℃로 낮추었다. 여기에 THF에 녹은 CH3MgBr을 천천히 넣고, 상온으로 온도를 서서히 올린 후 5 시간 동안 교반하였다. 반응종료 후 H20 : EA에 층분리를 한 후 컬럼정제(N-HEXANE : MC)하여 <중간체 1-1> 2.0 g (수율 73%) 수득하였다. (m/z= 280)
Intermediate 1-0 (2.3 g, 0.010 mol) was added, and THF (30 mL) was added thereto. The mixture was stirred and dissolved, and the temperature was lowered to 0 ° C. CH3MgBr dissolved in THF was slowly added thereto, the temperature was slowly raised to room temperature, and the mixture was stirred for 5 hours. After completion of the reaction, the reaction mixture was subjected to layer separation with H 2 O: EA, followed by column purification (N-HEXANE: MC) to obtain 2.0 g (yield 73%) of Intermediate 1-1. (m / z = 280)

(3) (3) 제조예Manufacturing example 3 : 중간체 1-2의 합성 3: Synthesis of intermediate 1-2

Figure 112014127180143-pat00117
Figure 112014127180143-pat00117

중간체 1-1(2.8 g, 0.010 mol)을 투입하고, 상온에서 소량의 H2SO4를 넣어 5시간 동안 교반하였다. 반응종료 후 H20: EA에 층분리를 한 후 컬럼정제(N-HEXANE : MC)하여 <중간체 1-2> 1.7 g(수율 62%) 수득하였다. (m/z= 278)
Intermediate 1-1 (2.8 g, 0.010 mol) was added thereto, and a small amount of H2SO4 was added at room temperature, followed by stirring for 5 hours. After completion of the reaction, the reaction mixture was subjected to layer separation with H 2 O: EA and then subjected to column purification (N-HEXANE: MC) to obtain <Intermediate 1-2> (1.7 g, yield 62%). (m / z = 278)

(4) (4) 제조예Manufacturing example 4 : 중간체 1-3의 합성 4: Synthesis of intermediate 1-3

Figure 112014127180143-pat00118
Figure 112014127180143-pat00118

중간체 1-2(2.8 g, 0.010 mol)에 bromobenzene(1.7 g, 0.011 mol), Pd(dba)2 (0.5 g, 0.0005 mol), sodium-tert-butoxide(1.9 g, 0.020 mol)에 Toluene 100 mL를 넣고 95 ℃에서 4시간 교반하여 반응시켰다. 반응종료 후 H20 : MC에 층분리를 한 후 컬럼정제(N-HEXANE : MC)하여 <중간체 1-1> 2.2 g(수율 62%) 수득하였다. (m/z= 354)
100 mL of toluene was added to bromobenzene (1.7 g, 0.011 mol), Pd (dba) 2 (0.5 g, 0.0005 mol) and sodium tert-butoxide (1.9 g, 0.020 mol) And the mixture was reacted at 95 ° C for 4 hours with stirring. After completion of the reaction, the reaction mixture was subjected to layer separation with H 2 O: MC, followed by column purification (N-HEXANE: MC) to obtain 2.2 g (yield 62%) of Intermediate 1-1. (m / z = 354)

(5) (5) 제조예Manufacturing example 5 : 화합물 1의 합성 5: Synthesis of Compound 1

Figure 112014127180143-pat00119
Figure 112014127180143-pat00119

중간체 1-3(3.5 g, 0.010 mol)에 diphenylamine(3.7 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 1> 2.0 g(수율 70%)을 얻었다.2.0 g (yield 70%) of <compound 1> was obtained by synthesizing diphenylamine (3.7 g, 0.022 mol) in Intermediate 1-3 (3.5 g, 0.010 mol) .

H-NMR (200MHz, CDCl3):δ ppm, 2H(6.80/d, 5.91/d, 5.69/d, 1.72/s) 5H(6.81/m) 10H(7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (6.80 / d, 5.91 / d, 5.69 / d, 1.72 / s) 5H (6.81 / m) 10H (7.20 / m, 6.63 / d)

LC/MS: m/z= 620[(M+1)+]
LC / MS: m / z = 620 [(M + 1) &lt; + &

실시예Example 2 : 화합물 2 합성 2: Synthesis of compound 2

(1) (One) 제조예Manufacturing example 1 : 중간체 2-1의 합성 1: Synthesis of intermediate 2-1

Figure 112014127180143-pat00120
Figure 112014127180143-pat00120

1-bromo-4-phenylnaphthalene(2.8 g, 0.010 mol)에 p-toluidine(1.2 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 2-1> 1.7 g (수율 56%)을 얻었다. (m/z=309)
(1.2 g, 0.011 mol) was added to 1-bromo-4-phenylnaphthalene (2.8 g, 0.010 mol) in the same manner as in Example 1- (Yield: 56%). (m / z = 309)

(2) (2) 제조예Manufacturing example 2 : 화합물 2의 합성 2: Synthesis of Compound 2

Figure 112014127180143-pat00121
Figure 112014127180143-pat00121

중간체 1-3(3.5 g, 0.010 mol)에 중간체 2-1(6.8 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 2> 5.9 g(수율 66%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 2-1 (6.8 g, 0.022 mol) was added to intermediate 1-3 (3.5 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(8.49/d, 8.07/d, 7.78/d, 7.54/m, 7.53/m, 7.41/m, 7.20/m, 7.04/d, 6.80/d, 6.63/d, 5.91/d, 5.69/s, 2.34/s, 1.72/s) 4H(7.79/d, 7.51/m, 6.98/d, 6.51/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (8.49 / d, 8.07 / d, 7.78 / d, 7.54 / m, 7.53 / m, 7.41 / m, 7.20 / m, 7.04 d, 6.81 / d, 6.63 / d, 5.91 / d, 5.69 / s, 2.34 / s, 1.72 / s)

LC/MS: m/z= 901[(M+1)+]
LC / MS: m / z = 901 [(M + 1) &lt; + &

실시예Example 3 : 화합물 3 합성 3: Synthesis of compound 3

(1) (One) 제조예Manufacturing example 1 : 중간체 3-1 합성 1: Intermediate 3-1 Synthesis

Figure 112014127180143-pat00122
Figure 112014127180143-pat00122

3,5-dimethylaniline(1.2 g, 0.010 mol)에 4-bromodibenzo[b,d]thiophene (2.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 3-1> 1.5 g(수율 51%)을 얻었다. (m/z=303)
Synthesis was conducted in the same manner as in Example 1 (4) except that 4-bromodibenzo [b, d] thiophene (2.9 g, 0.011 mol) was added to 3,5-dimethylaniline (1.2 g, 0.010 mol) 1 &gt; 1.5 g (yield: 51%). (m / z = 303)

(2) (2) 제조예Manufacturing example 2 : 화합물 3의 합성 2: Synthesis of Compound 3

Figure 112014127180143-pat00123
Figure 112014127180143-pat00123

중간체 1-3(3.5 g, 0.010 mol)에 중간체 3-1(6.7 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 3> 5.4 g(수율 61%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4) to give Intermediate 3-1 (6.7 g, 0.022 mol) and Intermediate 1-3 (3.5 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(8.45/d, 7.98/d, 7.81/d, 7.52/m, 7.50/m, 7.27/m, 7.20/m, 6.86/d, 6.80/d, 6.71/s, 6.63/d, 5.91/d, 5.69/s, 1.72/s) 4H(6.36/s, 2.34/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (8.45 / d, 7.98 / d, 7.81 / d, 7.52 / m, 7.50 / m, 7.27 / m, 7.20 / m, 6.86 s), 4H (6.36 / s, 2.34 / s), 6.71 / s, 6.71 /

LC/MS: m/z= 889[(M+1)+]
LC / MS: m / z = 889 [(M + 1) &lt; + &

실시예Example 4 : 화합물 4 합성 4: Synthesis of compound 4

(1) (One) 제조예Manufacturing example 1 : 중간체 4-1의 합성 1: Synthesis of Intermediate 4-1

Figure 112014127180143-pat00124
Figure 112014127180143-pat00124

중간체 1-2(2.8 g, 0.010 mol)에 1-bromo-4-methylbenzene(1.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 4-1> 2.4 g (수율 66%)을 얻었다. (m/z=368)
Synthesis was conducted in the same manner as in Example 1 (4) except that 1-bromo-4-methylbenzene (1.9 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) g (yield 66%). (m / z = 368)

(2) (2) 제조예Manufacturing example 2 : 중간체 4-2의 합성 2: Synthesis of intermediate 4-2

Figure 112014127180143-pat00125
Figure 112014127180143-pat00125

3,5-dimethylaniline(1.2 g, 0.010 mol)에 (4-bromophenyl)trimethylsilane (2.5 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 4-2> 1.5 g(수율 56%)을 얻었다. (m/z=269)
(4-bromophenyl) trimethylsilane (2.5 g, 0.011 mol) was added to 3,5-dimethylaniline (1.2 g, 0.010 mol) g (yield: 56%). (m / z = 269)

(3) (3) 제조예Manufacturing example 3 : 화합물 4의 합성 3: Synthesis of Compound 4

Figure 112014127180143-pat00126
Figure 112014127180143-pat00126

중간체 4-1(3.7 g, 0.010 mol)에 중간체 4-2(5.9 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 4> 6.2 g(수율 74%)을 얻었다. (m/z=295)Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 4-2 (5.9 g, 0.022 mol) was added to Intermediate 4-1 (3.7 g, 0.010 mol) ). (m / z = 295)

H-NMR (200MHz, CDCl3):δ ppm, 2H(6.98/d, 6.80/d, 6.71/s, 6.51/d, 5.91/d, 5.69/s, 1.72/s) 4H(7.15/d, 6.61/d, 6.36/d) 5H(2.34/s) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (6.98 / d, 6.80 / d, 6.71 / s, 6.51 / d, 5.91 / d, 5.69 / s, 1.72 / s) 4H (7.15 / d, 6.61 / d, 6.36 / d) 5H (2.34 / s) 6H (0.25 / s)

LC/MS: m/z=835 [(M+1)+]
LC / MS: m / z = 835 [(M + 1) &lt; + &

실시예Example 5 : 화합물 5 합성 5: Synthesis of compound 5

(1) (One) 제조예Manufacturing example 1 : 중간체 5-1의 합성 1: Synthesis of intermediate 5-1

Figure 112014127180143-pat00127
Figure 112014127180143-pat00127

1-bromo-4-isocyanobenzene(1.8 g, 0.010 mol)에 4-tert-butylaniline(1.7 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 5-1> 1.7 g(수율 67%)을 얻었다. (m/z=250)
(Intermediate 5-1) was synthesized in the same manner as in Example 1 (4) except that 4-tert-butylaniline (1.7 g, 0.011 mol) was added to 1-bromo-4-isocyanobenzene (1.8 g, 0.010 mol) 1.7 g (yield 67%) was obtained. (m / z = 250)

(2) (2) 제조예Manufacturing example 2 : 화합물 5의 합성 2: Synthesis of compound 5

Figure 112014127180143-pat00128
Figure 112014127180143-pat00128

중간체 1-3(3.5 g, 0.010 mol)에 중간체 5-1(5.5 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 5> 4.3 g(수율 63%)을 얻었다.4.3 g (yield: 63%) of compound 5 was synthesized in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 5-1 (5.5 g, 0.022 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(7.20/m, 6.80/d, 6.63/d, 5.91/d, 5.69/s, 1.72/s) 4H(7.39/d, 7.01/d, 6.81/d, 6.55/d) 6H(1.35/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (7.20 / m, 6.80 / d, 6.63 / d, 5.91 / d, 5.69 / s, 1.72 / s) 4H (7.39 / d , 7.01 / d, 6.81 / d, 6.55 / d) 6H (1.35 / s)

LC/MS: m/z=783 [(M+1)+]
LC / MS: m / z = 783 [(M + 1) &lt; + &

실시예Example 6 : 화합물 6 합성 6: Synthesis of Compound 6

(1) (One) 제조예Manufacturing example 1 : 중간체 6-1의 합성 1: Synthesis of intermediate 6-1

Figure 112014127180143-pat00129
Figure 112014127180143-pat00129

중간체 1-2(2.8 g, 0.010 mol)에 4-bromobiphenyl(2.5 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 6-1> 2.8 g(수율 66%)을 얻었다. (m/z=430)
(2.5 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol), and 2.8 g (yield: 66%) of Intermediate 6-1 was synthesized in the same manner as in Example 1- %). (m / z = 430)

(2) (2) 제조예Manufacturing example 2 : 화합물 6의 합성 2: Synthesis of Compound 6

Figure 112014127180143-pat00130
Figure 112014127180143-pat00130

중간체 6-1(4.3 g, 0.010 mol)에 중간체 3-1(6.6 g, 0.022 mol)를 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 6> 5.9 g(수율 61%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 3-1 (6.6 g, 0.022 mol) was added to Intermediate 6-1 (4.3 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m) 2H(8.45/d, 7.98/d, 7.81/d, 7.54/d, 7.52/d, 7.52/m, 7.51/m, 7.50/m, 7.27/m, 6.86/d, 6.80/d, 6.71/s, 6.69/d, 5.91/d, 5.69/s, 1.72/s) 4H(6.36/d, 2.34/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m) 2H (8.45 / d, 7.98 / d, 7.81 / d, 7.54 / d, 7.52 / d, 7.52 / m, 7.51 / m, 7.50 d, 6.71 / s, 6.69 / d, 5.91 / d, 5.69 / s, 1.72 / s) 4H (6.36 / d, 2.34 / s)

LC/MS: m/z= 965[(M+1)+]
LC / MS: m / z = 965 [(M + 1) &lt; + &

실시예Example 7 : 화합물 7 합성 7: Synthesis of Compound 7

(1) (One) 제조예Manufacturing example 1 : 화합물 7의 합성 1: Synthesis of Compound 7

Figure 112014127180143-pat00131
Figure 112014127180143-pat00131

중간체 1-3(3.5 g, 0.010 mol)에 9H-carbazole(3.7 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 7> 4.5 g(수율 73%)을 얻었다.4.5 g (yield: 73%) of Compound 7 was synthesized in the same manner as in Example 1 (4) except that 9H-carbazole (3.7 g, 0.022 mol) was added to Intermediate 1-3 &Lt; / RTI >

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m ) 2H(8.55/d, 8.12/d, 7.94/d, 7.63/d, 7.50/m, 7.33/m, 7.29/m, 7.25/m, 7.20/m, 7.05/d, 6.64/d, 6.63/d, 6.40/s, 1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (8.55 / d, 8.12 / d, 7.94 / d, 7.63 / d, 7.50 / m, 7.33 / m, 7.29 / m, 7.25 / m, 7.20 / m, 7.05 / d, 6.64 / d, 6.63 / d, 6.40 / s, 1.72 / s)

LC/MS: m/z= 616[(M+1)+]
LC / MS: m / z = 616 [(M + 1) &lt; + &

실시예Example 8 : 화합물 8 합성 8: Compound 8 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 8-1의 합성 1: Synthesis of Intermediate 8-1

Figure 112014127180143-pat00132
Figure 112014127180143-pat00132

중간체 1-3(3.5 g, 0.010 mol)에 phenyl-boronic-acid(1.4 g, 0.012 mol), Pd(pph3)4(0.6 g, 0.0005 mol), potassium carbonate(2.8 g, 0.020 mol)에 THF 100 mL를 넣고 65 ℃에서 18 시간 동안 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층 분리 후 컬럼정제(N-HEXANE : MC)하여 <중간체 7-2> 2.0 g (수율 51%) 수득하였다. (m/z=395)
To 1.4 g (0.012 mol) of phenylboronic acid, Pd (PPh3) 4 (0.6 g, 0.0005 mol) and potassium carbonate (2.8 g, 0.020 mol) in THF 100 mL, and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (N-HEXANE: MC) to obtain 2.0 g (yield: 51%) of Intermediate 7-2. (m / z = 395)

(2) (2) 제조예Manufacturing example 2 : 중간체 8-2의 합성 2: Synthesis of Intermediate 8-2

Figure 112014127180143-pat00133
Figure 112014127180143-pat00133

11,12-dihydroindolo[2,3-a]carbazole(2.6 g, 0.010 mol)에 2-bromo-4,6-diphenyl-1,3,5-triazine(3.4 g, 0.011 mol), NaH(0.8 g, 0.030 mol)에 DMF 80 mL를 넣고 12 시간 동안 교반하여 반응시켰다. 반응종료 후 H20 : MC에 층분리를 한 후 컬럼정제(N-HEXANE : MC)하여 <중간체 8-2> 2.3 g(수율 47%) 수득하였다. (m/z= 487)
2-bromo-4,6-diphenyl-1,3,5-triazine (3.4 g, 0.011 mol), NaH (0.8 g, 0.011 mol) was added to 11,12-dihydroindolo [2,3- , 0.030 mol) was added 80 mL of DMF and stirred for 12 hours. After the completion of the reaction, the reaction mixture was subjected to layer separation with H 2 O: MC, followed by column purification (N-HEXANE: MC) to obtain 2.3 g (yield: 47%) of Intermediate 8-2. (m / z = 487)

(3) (3) 제조예Manufacturing example 3 : 화합물 8의 합성 3: Synthesis of Compound 8

Figure 112014127180143-pat00134
Figure 112014127180143-pat00134

중간체 8-1(4.0 g, 0.010 mol)에 중간체 8-2(5.3 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 8> 4.5 g(수율 53%)을 얻었다.4.5 g (yield: 53%) of Compound 8 was synthesized in the same manner as in Example 1- (4), except that Intermediate 8-1 (4.0 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.12/d, 7.57/d, 7.05/d, 6.64/d, 6.40/s) 2H(8.55/d, 7.94/d, 7.52/d, 7.33/m, 7.25/m, 7.20/m, 6.81/m, 6.63/d, 1.72/s) 3H(7.41/m) 4H(8.28/d) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.12 / d, 7.57 / d, 7.05 / d, 6.64 / d, 6.40 / s) 2H (8.55 / d, 7.94 / d, 7.52 / d, 7.33 m, 7.25 / m, 7.20 / m, 6.81 / m, 6.63 / d, 1.72 / s) 3H (7.41 /

LC/MS: m/z=848 [(M+1)+]
LC / MS: m / z = 848 [(M + 1) &lt; + &

실시예Example 9 : 화합물 9 합성 9: Synthesis of Compound 9

(1) (One) 제조예Manufacturing example 1 : 중간체 9-1의 합성 1: Synthesis of intermediate 9-1

Figure 112014127180143-pat00135
Figure 112014127180143-pat00135

2,4,6-tribromo-1,3,5-triazine(3.2 g, 0.010 mol)에 phenyl boronic acid (1.4 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 9-1> 1.9 g(수율 61%)을 얻었다. (m/z=314)
Was synthesized in the same manner as in Example 8- Preparation Example (1), except that phenyl boronic acid (1.4 g, 0.012 mol) was added to 2,4,6-tribromo-1,3,5-triazine (3.2 g, 0.010 mol) 1.9 g (yield: 61%) of Intermediate 9-1 was obtained. (m / z = 314)

(2) (2) 제조예Manufacturing example 2 : 중간체 9-2의 합성 2: Synthesis of intermediate 9-2

Figure 112014127180143-pat00136
Figure 112014127180143-pat00136

중간체 9-1(3.1 g, 0.010 mol)에 biphenyl-4-ylboronic acid(2.4 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 9-2> 2.5 g (수율 65%)을 얻었다. (m/z=388)
Intermediate 9-2 was synthesized in the same manner as in Example 8- (1) except that biphenyl-4-ylboronic acid (2.4 g, 0.012 mol) was added to Intermediate 9-1 (3.1 g, 0.010 mol) (Yield: 65%). (m / z = 388)

(3) (3) 제조예Manufacturing example 3 : 중간체 9-3의 합성 3: Synthesis of intermediate 9-3

Figure 112014127180143-pat00137
Figure 112014127180143-pat00137

중간체 1-2(2.8 g, 0.010 mol)에 중간체 9-2(4.3 g, 0.011 mol)을 넣고 실시예 8-제조예 (2)와 동일한 방법으로 합성하여 <중간체 9-3> 3.4 g(수율 58%)을 얻었다. (m/z=585)
Intermediate 9-2 (4.3 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 8- 58%). (m / z = 585)

(4) (4) 제조예Manufacturing example 4 : 중간체 9-4의 합성 4: Synthesis of intermediate 9-4

Figure 112014127180143-pat00138
Figure 112014127180143-pat00138

중간체 9-3(5.9 g, 0.010 mol)에 phenyl boronic acid(1.4 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 9-4> 3.6 g (수율 57%)을 얻었다. (m/z=627)
Synthesis was conducted in the same manner as in Example 8- (1) except that phenyl boronic acid (1.4 g, 0.012 mol) was added to Intermediate 9-3 (5.9 g, 0.010 mol) %). (m / z = 627)

(5) (5) 제조예Manufacturing example 5 : 중간체 9-5의 합성 5: Synthesis of intermediate 9-5

Figure 112014127180143-pat00139
Figure 112014127180143-pat00139

11,12-dihydroindolo[2,3-a]carbazole(2.6 g, 0.010 mol)에 bromobenzene (1.7 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 9-5> 1.6 g(수율 49%)을 얻었다. (m/z=332)
Synthesis was conducted in the same manner as in Example 1 (4) except that bromobenzene (1.7 g, 0.011 mol) was added to 11,12-dihydroindolo [2,3-a] carbazole (2.6 g, 0.010 mol) 5> 1.6 g (yield: 49%). (m / z = 332)

(6) (6) 제조예Manufacturing example 6 : 화합물 9의 합성 6: Synthesis of Compound 9

Figure 112014127180143-pat00140
Figure 112014127180143-pat00140

중간체 9-4(6.3 g, 0.010 mol)에 중간체 9-5(3.6 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 9> 5.9 g(수율 64%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 9-5 (3.6 g, 0.011 mol) was added to Intermediate 9-4 (6.3 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.12/d, 7.57/d, 7.45/m, 7.11/d, 6.81/s, 6.73/d, 6.64/d, 6.40/s) 2H(8.55/d, 8.28/d, 7.94/d, 7.85/d, 7.58/m, 7.50/d, 7.33/m, 7.25/m, 7.25/d, 1.72/s) 3H(7.41/m) 4H(7.52/d) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.12 / d, 7.57 / d, 7.45 / m, 7.11 / d, 6.81 / s, 6.73 / d, 6.64 / d, 6.40 / s) 2H (8.55 m), 7.25 / d, 1.72 / s), 3H (7.41 / m), 4H (7.52 / d, 7.38 / d, 8.28 / d, 7.94 / d, 7.85 / d, 7.58 / ) 6H (7.51 / m)

LC/MS: m/z= 924[(M+1)+]
LC / MS: m / z = 924 [(M + 1) &lt; + &

실시예Example 10 : 화합물 10 합성 10: Compound 10 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 10-1의 합성 1: Synthesis of intermediate 10-1

Figure 112014127180143-pat00141
Figure 112014127180143-pat00141

9,10-dibromoanthracene(3.4 g, 0.010 mol)에 naphthalen-1-ylboronic acid(2.0 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 10-1> 2.1 g(수율 54%)을 얻었다. (m/z=383)
Synthesis was conducted in the same manner as in Example 8- (1) except that naphthalen-1-ylboronic acid (2.0 g, 0.012 mol) was added to 9,10-dibromoanthracene (3.4 g, 0.010 mol) g (yield: 54%). (m / z = 383)

(2) (2) 제조예Manufacturing example 2 : 중간체 10-2의 합성 2: Synthesis of intermediate 10-2

Figure 112014127180143-pat00142
Figure 112014127180143-pat00142

중간체 1-2(2.8 g, 0.010 mol)에 중간체 10-1(4.2 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 10-2> 4.1 g(수율 71%)을 얻었다. (m/z=580)
Intermediate 10-1 (4.2 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (4) 71%). (m / z = 580)

(3) (3) 제조예Manufacturing example 3 : 화합물 10의 합성 3: Synthesis of compound 10

Figure 112014127180143-pat00143
Figure 112014127180143-pat00143

중간체 10-2(5.8 g, 0.010 mol)에 phenyl boronic acid(2.8 g, 0.024 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <화합물 10> 4.5 g(수율 68%)을 얻었다. (m/z=333)4.5 g (yield 68%) of Compound 10 was synthesized in the same manner as in Example 8- (1) except that phenyl boronic acid (2.8 g, 0.024 mol) was added to Intermediate 10-2 (5.8 g, &Lt; / RTI > (m / z = 333)

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 7.61/m) 2H(7.91/d, 7.90/d, 7.55/m, 7.41/m, 7.39/m, 7.38/d, 7.11/d, 6.81/s, 6.73/d, 1.72/s) 4H(7.52/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 7.61 / m) 2H (7.91 / d, 7.90 / d, 7.55 / m, 7.41 d, 7.51 / m, 7.39 / m, 7.38 / d, 7.11 / d, 6.81 /

LC/MS: m/z=664 [(M+1)+]
LC / MS: m / z = 664 [(M + 1) &lt; + &

실시예Example 11 : 화합물 11 합성 11: Compound 11 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 11-1의 합성 1: Synthesis of intermediate 11-1

Figure 112014127180143-pat00144
Figure 112014127180143-pat00144

4-bromo-naphthalen-1-ol(2.2 g, 0.010 mol)에 phenyl-boronic-acid(1.4 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 11-1> 1.6 g(수율 73%)을 얻었다. (m/z=220)
Boronic acid (1.4 g, 0.012 mol) was added to 4-bromo-naphthalen-1-ol (2.2 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 8- 1> 1.6 g (yield: 73%). (m / z = 220)

(2) (2) 제조예Manufacturing example 2 : 중간체 11-2의 합성 2: Synthesis of intermediate 11-2

Figure 112014127180143-pat00145
Figure 112014127180143-pat00145

중간체 11-1(2.2 g, 0.010 mol)에 trifluoromethane sulfonic anhydride(3.1 g, 0.011 mol), pyridine(1.0 g, 0.013 mol), potassium carbonate(4.1 g, 0.030 mol)에 methyl chloride 100 mL를 넣고 0 ℃에서 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 <중간체 11-2> 2.5 g(수율 70%)수득하였다.(m/z=352)
100 mL of methyl chloride was added to trifluoromethane sulfonic anhydride (3.1 g, 0.011 mol), pyridine (1.0 g, 0.013 mol) and potassium carbonate (4.1 g, 0.030 mol) Lt; / RTI &gt; After completion of the reaction, the reaction mixture was cooled, and the product was separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 2.5 g (m / z = 352)

(3) (3) 제조예Manufacturing example 3 : 중간체 11-3의 합성 3: Synthesis of intermediate 11-3

Figure 112014127180143-pat00146
Figure 112014127180143-pat00146

중간체 11-2(3.5 g, 0.010 mol)에 aniline(1.0 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 11-3> 1.5 g(수율 51%)을 얻었다. (m/z=295)
1.5 g (yield: 51%) of Intermediate 11-3 was synthesized in the same manner as in Example 1 (4) except that aniline (1.0 g, 0.011 mol) was added to Intermediate 11-2 (3.5 g, 0.010 mol) &Lt; / RTI > (m / z = 295)

(4) (4) 제조예Manufacturing example 4 : 중간체 11-4의 합성 4: Synthesis of intermediate 11-4

Figure 112014127180143-pat00147
Figure 112014127180143-pat00147

중간체 11-3(3.0 g, 0.010 mol)에 1,4-dibromobenzene(2.6 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 11-4> 2.4 g(수율 53%)을 얻었다. (m/z=450)
Synthesis was conducted in the same manner as in Example 1 (4), except that 1,4-dibromobenzene (2.6 g, 0.011 mol) was added to Intermediate 11-3 (3.0 g, 0.010 mol) Yield: 53%). (m / z = 450)

(5) (5) 제조예Manufacturing example 5 : 중간체 11-5의 합성 5: Synthesis of intermediate 11-5

Figure 112014127180143-pat00148
Figure 112014127180143-pat00148

중간체 1-2(2.8 g, 0.010 mol)에 중간체 11-4(5.0 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 11-5> 4.3 g(수율 66%)을 얻었다. (m/z=647)
Intermediate 11-4 (5.0 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (4) 66%). (m / z = 647)

(6) (6) 제조예Manufacturing example 6 : 화합물 11의 합성 6: Synthesis of Compound 11

Figure 112014127180143-pat00149
Figure 112014127180143-pat00149

중간체 11-5(6.5 g, 0.010 mol)에 9H-carbazole(3.7 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 11> 6.0 g(수율 66%)을 얻었다.6.0 g (Yield: 66%) of Compound 11 was synthesized in the same manner as Example 1-Preparation Example (4), except that 9H-carbazole (3.7 g, 0.022 mol) was added to Intermediate 11-5 (6.5 g, &Lt; / RTI >

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.43/d, 7.85/d, 7.46/m, 7.41/m, 7.32/m, 6.99/s, 6.81/m, 6.76/s) 2H(8.55/d, 8.12/d, 7.94/d, 7.79/d, 7.63/d, 7.51/m, 7.50/m, 7.33/m, 7.29/m, 7.25/m, 7.20/m, 7.05/d, 6.64/d, 6.63/d, 6.40/s, 1.72/s) 4H(6.38/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.43 / d, 7.85 / d, 7.46 / m, 7.41 / m, 7.32 / m, 6.99 / s, 6.81 / m, 6.76 / s) 2H (8.55 m, 7.29 / m, 7.25 / m, 7.20 / m, 7.05 / d, 6.64 / d , 6.63 / d, 6.40 / s, 1.72 / s) 4H (6.38 / d)

LC/MS: m/z= 910[(M+1)+]
LC / MS: m / z = 910 [(M + 1) &lt; + &

실시예Example 12 : 화합물 12 합성 12: Compound 12 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 12-1의 합성 1: Synthesis of Intermediate 12-1

Figure 112014127180143-pat00150
Figure 112014127180143-pat00150

중간체 1-2(2.8 g, 0.010 mol)에 3-bromo-9-phenyl-9H-carbazole(3.5 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 12-1> 3.7 g(수율 72%)을 얻었다. (m/z=519)
Synthesis was conducted in the same manner as in Example 1 (4) except that 3-bromo-9-phenyl-9H-carbazole (3.5 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) -1> 3.7 g (yield 72%). (m / z &lt; / RTI &gt; = 519)

(2) (2) 제조예Manufacturing example 2 : 화합물 12의 합성 2: Synthesis of Compound 12

Figure 112014127180143-pat00151
Figure 112014127180143-pat00151

중간체 12-1(5.2 g, 0.010 mol)에 2-phenyl-1H-indole(4.2 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 12> 4.8 g(수율 58%)을 얻었다.The compound 12 was synthesized in the same manner as in Example 1 (4) except that 2-phenyl-1H-indole (4.2 g, 0.022 mol) was added to Intermediate 12-1 (5.2 g, 0.010 mol) Yield: 58%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 7.45/m, 7.38/d, 7.25/m, 6.77/d, 6.75/s) 2H(7.93/d, 7.58/m, 7.50/d, 7.41/m, 7.05/d, 6.87/m, 6.64/d, 6.60/s, 6.40/s, 1.72/s) 3H(7.94/d, 7.33/m) 4H(7.79/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 7.45 / m, 7.38 / d, 7.25 / m, 6.77 / d, 6.75 / s) 2H (7.93 / d, 7.58 / m, 7.50 d, 7.41 / m, 7.05 / d, 6.87 / m, 6.64 / d, 6.60 / s, 6.40 / s, 1.72 / s) )

LC/MS: m/z=833 [(M+1)+]
LC / MS: m / z = 833 [(M + 1) &lt; + &

실시예Example 13 : 화합물 13 합성 13: Compound 13 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 13-1의 합성 1: Synthesis of intermediate 13-1

Figure 112014127180143-pat00152
Figure 112014127180143-pat00152

중간체 1-2(2.8 g, 0.010 mol)에 4-bromo-N,N-dip-tolylaniline(3.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 13-1> 3.6 g(수율 66%)을 얻었다. (m/z=549)
Synthesis was conducted in the same manner as in Example 1 (4) except that 4-bromo-N, N-dip-tolylaniline (3.9 g, 0.011 mol) was added to Intermediate 1-2 (2.8 g, 0.010 mol) -1> 3.6 g (yield 66%). (m / z = 549)

(2) (2) 제조예Manufacturing example 2 : 화합물 13의 합성 2: Synthesis of Compound 13

Figure 112014127180143-pat00153
Figure 112014127180143-pat00153

중간체 13-1(5.5 g, 0.010 mol)에 9H-pyrido[3,4-b]indole(3.7 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 13> 4.8 g (수율 59%)을 얻었다.The compound was synthesized in the same manner as in Example 1 (4) except that 9H-pyrido [3,4-b] indole (3.7 g, 0.022 mol) was added to Intermediate 13-1 (5.5 g, 0.010 mol) > 4.8 g (yield: 59%).

H-NMR (200MHz, CDCl3):δ ppm, 2H(8.87/s, 8.55/d, 8.43/d, 7.94/d, 7.38/d, 7.33/m, 7.25/m, 7.05/d, 6.64/d, 6.40/s, 2.34/s, 1.72/s) 4H(6.98/d, 6.51/d, 6.38/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (8.87 / s, 8.55 / d, 8.43 / d, 7.94 / d, 7.38 / d, 7.33 / m, 7.25 / m, 7.05 / d, 6.64 / d , 6.40 / s, 2.34 / s, 1.72 / s) 4H (6.98 / d, 6.51 / d, 6.38 / d)

LC/MS: m/z= 814[(M+1)+]
LC / MS: m / z = 814 [(M + 1) &lt; + &

실시예Example 14 : 화합물 14 합성 14: Compound 14 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 14-1의 합성 1: Synthesis of intermediate 14-1

Figure 112014127180143-pat00154
Figure 112014127180143-pat00154

중간체 1-2(2.8 g, 0.012 mol)에 phenyl boronic acid(2.8 g, 0.024 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 14-1> 2.1 g(수율 59%)을 얻었다. (m/z=361)
2.1 g (Intermediate 14-1) (yield: 2.1 g) was obtained by the same method as in the preparation example (1) of Example 8, except that phenyl boronic acid (2.8 g, 0.024 mol) 59%). (m / z = 361)

(2) (2) 제조예Manufacturing example 2 : 중간체 14-2의 합성 2: Synthesis of intermediate 14-2

Figure 112014127180143-pat00155
Figure 112014127180143-pat00155

3-bromonaphthalen-1-ol(2.2 g, 0.010 mol)에 phenyl boronic acid(1.4 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 14-2> 1.3 g(수율 59%)을 얻었다. (m/z=220)
1.3 g of Intermediate 14-2 was synthesized in the same manner as in Example 8- (1) except that phenyl boronic acid (1.4 g, 0.012 mol) was added to 3-bromonaphthalen-1-ol (2.2 g, 0.010 mol) (Yield: 59%). (m / z = 220)

(3) (3) 제조예Manufacturing example 3 : 중간체 14-3의 합성 3: Synthesis of intermediate 14-3

Figure 112014127180143-pat00156
Figure 112014127180143-pat00156

중간체 14-2(2.2 g, 0.010 mol)에 trifluoromethane sulfonic anhydride(3.1 g, 0.011 mol), pyridine(1.0 g, 0.013 mol)을 넣고 실시예 11-제조예 (2)과 동일한 방법으로 합성하여 <중간체 14-3> 2.4 g(수율 67%)을 얻었다. (m/z=352)
Synthesis was conducted in the same manner as in Example 11- (2) except that trifluoromethane sulfonic anhydride (3.1 g, 0.011 mol) and pyridine (1.0 g, 0.013 mol) were added to Intermediate 14-2 (2.2 g, 0.010 mol) 14-3> 2.4 g (yield 67%). (m / z = 352)

(4) (4) 제조예Manufacturing example 4 : 중간체 14-4의 합성 4: Synthesis of intermediate 14-4

Figure 112014127180143-pat00157
Figure 112014127180143-pat00157

9,10-dibromoanthracene(3.4 g, 0.010 mol)에 bis(pinacolato)dibron(5.0 g, 0.024 mol), PdCl2(dppf)(0.4 g, 0.0005 mol), potassium-acetate(2.7 g, 0.020 mol)에 1,4-dioxane 100 mL를 넣고 95 ℃에서 24시간 교반하여 반응시켰다.반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 중간체 14- 3.1 g(수율 71%) 수득하였다. (m/z=430)
To a solution of bis (pinacolato) dibron (5.0 g, 0.024 mol), PdCl 2 (dppf) (0.4 g, 0.0005 mol) and potassium acetate (2.7 g, 0.020 mol) in 9,10-dibromoanthracene (3.4 g, 0.010 mol) , And 4-dioxane (100 mL) were added and the mixture was reacted for 24 hours at 95 ° C. After completion of the reaction, the reaction mixture was cooled and separated into H 2 O: MC and purified by column chromatography (n-hexane: MC) . (m / z = 430)

(5) (5) 제조예Manufacturing example 5 : 중간체 14-5의 합성 5: Synthesis of intermediate 14-5

Figure 112014127180143-pat00158
Figure 112014127180143-pat00158

중간체 14-3(3.5 g, 0.010 mol)에 중간체 14-4(5.2 g, 0.012 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 14-5> 3.2 g(수율 64%)을 얻었다. (m/z=506)
Intermediate 14-4 (5.2 g, 0.012 mol) was added to Intermediate 14-3 (3.5 g, 0.010 mol) and synthesized in the same manner as in Example 8- 64%). (m / z = 506)

(6) (6) 제조예Manufacturing example 6 : 중간체 14-6의 합성 6: Synthesis of Intermediate 14-6

Figure 112014127180143-pat00159
Figure 112014127180143-pat00159

중간체 14-5(6.1 g, 0.012 mol)에 1,4-dibromobenzene(2.4 g, 0.010 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 14-6> 3.4 g(수율 64%)을 얻었다. (m/z=535)
Intermediate 14-6 was synthesized in the same manner as in Example 8- (1) except that 1,4-dibromobenzene (2.4 g, 0.010 mol) was added to Intermediate 14-5 (6.1 g, 0.012 mol) Yield: 64%). (m / z = 535)

(7) (7) 제조예Manufacturing example 7 : 화합물 14의 합성 7: Synthesis of Compound 14

Figure 112014127180143-pat00160
Figure 112014127180143-pat00160

중간체 14-1(3.6 g, 0.010 mol)에 중간체 14-6(5.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 14> 4.7 g (수율 57%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 14-6 (5.9 g, 0.011 mol) was added to Intermediate 14-1 (3.6 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.08/d, 7.85/s, 7.76/s) 2H(7.55/m, 7.54/d, 7.11/d, 6.81/s, 6.73/d, 6.69/d, 1.72/s) 3H(7.41/m) 4H(7.91/d, 7.39/m) 6H(7.52/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.08 / d, 7.85 / s, 7.76 / s) 2H (7.55 / m, 7.54 / d, 7.11 / d, 6.81 / s, 6.73 (7.51 / d, 7.31 / m) 6H (7.52 / d, 7.51 / m)

LC/MS: m/z=817 [(M+1)+]
LC / MS: m / z = 817 [(M + 1) &lt; + &

실시예Example 15 : 화합물 15 합성 15: Compound 15 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 15-1의 합성 1: Synthesis of intermediate 15-1

Figure 112014127180143-pat00161
Figure 112014127180143-pat00161

4-chloroaniline(1.3 g, 0.010 mol)에 1-bromo-4-isopropylbenzene(2.2 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 15-1> 2.0 g(수율 55%)을 얻었다. (m/z=363)
2.0 g (0.011 mol) of 1-bromo-4-isopropylbenzene was added to 4-chloroaniline (1.3 g, 0.010 mol) (Yield: 55%). (m / z = 363)

(2) (2) 제조예Manufacturing example 2 : 화합물 15의 합성 2: Synthesis of compound 15

Figure 112014127180143-pat00162
Figure 112014127180143-pat00162

중간체 14-1(3.6 g, 0.010 mol)에 중간체 15-1(4.0 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 15> 3.5 g(수율 51%)을 얻었다.3.5 g (yield: 51%) of compound 15 was synthesized in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 14-1 (3.6 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 2H(7.41/m, 7.11/d, 6.81/s, 6.73/d, 2.87/s, 1.72/s) 4H(7.52/d, 7.51/m, 7.05/d, 6.55/d, 6.38/d, 1.20/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (7.41 / m, 7.11 / d, 6.81 / s, 6.73 / d, 2.87 / s, 1.72 / s) 4H (7.52 / d, 7.51 / m, 7.05 / d, 6.55 / d, 6.38 / d, 1.20 / s)

LC/MS: m/z=689 [(M+1)+]
LC / MS: m / z = 689 [(M + 1) &lt; + &

실시예Example 16 : 화합물 16 합성 16: Compound 16 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 16-1의 합성 1: Synthesis of intermediate 16-1

Figure 112014127180143-pat00163
Figure 112014127180143-pat00163

3,6-diphenyl-9H-carbazole(3.2 g, 0.010 mol)에 1,4-dibromobenzene(2.6 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 16-1> 2.9 g(수율 62%)을 얻었다. (m/z=474)
Dibromobenzene (2.6 g, 0.011 mol) was added to 3,6-diphenyl-9H-carbazole (3.2 g, 0.010 mol) in the same manner as in Example 1- 1> 2.9 g (yield: 62%). (m / z &lt; / RTI &gt; = 474)

(2) (2) 제조예Manufacturing example 2 : 화합물 16의 합성 2: Synthesis of Compound 16

Figure 112014127180143-pat00164
Figure 112014127180143-pat00164

중간체 14-1(3.6 g, 0.010 mol)에 중간체 16-1(5.2 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 16> 4.5 g(수율 59%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4) to obtain Intermediate 16-1 (5.2 g, 0.011 mol) and Intermediate 14-1 (3.6 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.18/d, 8.00/d, 7.87/d, 7.69/d) 2H(7.77/s, 7.37/d, 7.11/d, 6.81/s, 6.73/d, 6.63/d, 1.72/s) 4H(7.41/m) 8H(7.52/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.18 / d, 8.00 / d, 7.87 / d, 7.69 / d) 2H (7.77 / s, 7.37 / d, 7.11 / d, 6.81 / s, 6.73 / d, 6.63 / d, 1.72 / s) 4H (7.41 / m) 8H (7.52 / d, 7.51 /

LC/MS: m/z=755 [(M+1)+]
LC / MS: m / z = 755 [(M + 1) &lt; + &

실시예Example 17 : 화합물 17 합성 17: Compound 17 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 17-1의 합성 1: Synthesis of intermediate 17-1

Figure 112014127180143-pat00165
Figure 112014127180143-pat00165

9-bromo-10-phenylanthracene(3.3 g, 0.010 mol)에 bis(pinacolato)dibron (2.5 g, 0.012 mol)을 넣고 실시예 14-제조예 (4)과 동일한 방법으로 합성하여 <중간체 17-1> 2.4 g (수율 63%)을 얻었다. (m/z=380)
Intermediate 17-1 was synthesized in the same manner as in Example 14- (4) except that bis (pinacolato) dibron (2.5 g, 0.012 mol) was added to 9-bromo-10-phenylanthracene (3.3 g, 0.010 mol) 2.4 g (yield: 63%) was obtained. (m / z = 380)

(2) (2) 제조예Manufacturing example 2 : 중간체 17-2의 합성 2: Synthesis of intermediate 17-2

Figure 112014127180143-pat00166
Figure 112014127180143-pat00166

중간체 17-1(3.8 g, 0.010 mol)에 2,5-dichloro-4,6-dimethylpyrimidine( 1.9 g, 0.011 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 17-2> 2.1 g(수율 54%)을 얻었다. (m/z=394)
Synthesis was conducted in the same manner as in Example 8- (1) except that 2,5-dichloro-4,6-dimethylpyrimidine (1.9 g, 0.011 mol) was added to Intermediate 17-1 (3.8 g, 0.010 mol) -2> 2.1 g (yield 54%). (m / z = 394)

(3) (3) 제조예Manufacturing example 3 : 화합물 17의 합성 3: Synthesis of Compound 17

Figure 112014127180143-pat00167
Figure 112014127180143-pat00167

중간체 14-1(3.6 g, 0.010 mol)에 중간체 17-2(4.3 g, 0.011 mol)을 넣고 실시예 8-제조예 (2)와 동일한 방법으로 합성하여 <화합물 17> 4.0 g(수율 55%)을 얻었다.Compound (17) (4.0 g, yield 55%) was synthesized in the same manner as in Example 8 (2) except that Intermediate 17-2 (4.3 g, 0.011 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 2H(7.11/d, 6.81/s, 6.73/d, 2.33/s, 1.72/s) 3H(7.41/m) 4H(7.91/d, 7.39/m) 6H(7.52/d, 7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (7.11 / d, 6.81 / s, 6.73 / d, 2.33 / s, 1.72 / s) 3H (7.41 / m) 4H (7.91 / d, 7.39 / m ) 6H (7.52 / d, 7.51 / m)

LC/MS: m/z= 720[(M+1)+]
LC / MS: m / z = 720 [(M + 1) &lt; + &

실시예Example 18 : 화합물 18 합성 18: Compound 18 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 18-1의 합성 1: Synthesis of intermediate 18-1

Figure 112014127180143-pat00168
Figure 112014127180143-pat00168

diphenylamine(1.7 g, 0.010 mol)에 3,5-dibromophenylboronic acid(3.1 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 18-1> 2.0 g(수율 62%)을 얻었다. (m/z=323)
2.0 g (yield: 62%) of Intermediate 18-1 was synthesized in the same manner as in PREPARATION 1-PREPARATION (4), except that 3,5-dibromophenylboronic acid (3.1 g, 0.011 mol) %). (m / z = 323)

(2) (2) 제조예Manufacturing example 2 : 중간체 18-2의 합성 2: Synthesis of intermediate 18-2

Figure 112014127180143-pat00169
Figure 112014127180143-pat00169

중간체 18-1(3.8 g, 0.012 mol)에 (4-bromo-3,5-dimethylphenyl)trimethyl silane(2.6 g, 0.010 mol)을 넣고 실시예 8-제조예 (1)과 동일한 방법으로 합성하여 <중간체 18-2> 2.5 g(수율 55%)을 얻었다. (m/z=456)
(4-bromo-3,5-dimethylphenyl) trimethyl silane (2.6 g, 0.010 mol) was added to Intermediate 18-1 (3.8 g, 0.012 mol) 2.5 g (yield: 55%) of Intermediate 18-2 was obtained. (m / z = 456)

(3) (3) 제조예Manufacturing example 3 : 화합물 18의 합성 3: Synthesis of compound 18

Figure 112014127180143-pat00170
Figure 112014127180143-pat00170

중간체 14-1(3.6 g, 0.010 mol)에 중간체 18-2(5.0 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 18> 4.0 g(수율 51%)을 얻었다.Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4), except that Intermediate 18-2 (5.0 g, 0.011 mol) was added to Intermediate 14-1 (3.6 g, 0.010 mol) ).

H-NMR (200MHz, CDCl3):δ ppm, 2H(7.41/m, 7.31/s, 7.31/d, 6.81/m, 6.81/s, 6.73/d, 6.25/s, 2.59/s, 1.72/s) 3H(0.25/s) 4H(7.52/d, 7.51/m, 7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (7.41 / m, 7.31 / s, 7.31 / d, 6.81 / m, 6.81 / s, 6.73 / d, 6.25 / s, 2.59 / s, 1.72 / s ) 3H (0.25 / s) 4H (7.52 / d, 7.51 / m, 7.20 /

LC/MS: m/z= 782[(M+1)+]
LC / MS: m / z = 782 [(M + 1) &lt; + &

실시예Example 19 : 화합물 19 합성 19: Compound 19 Synthesis

(1) (One) 제조예Manufacturing example 1 : 화합물 19의 합성 1: Synthesis of Compound 19

Figure 112014127180143-pat00171
Figure 112014127180143-pat00171

화합물 1(6.2 g, 0.010 mol)을 THF 60 mL에 녹인 후 0 ℃로 냉각한 후 phenyl magnesium bromide(4.5 g, 0.025 mol)을 천천히 첨가한다. 그 후 온도를 실온으로 천천히 상승시킨 후 12 시간 동안 교반하여 증류수를 넣고, 반응을 종결시켰다. 그리고, EA를 이용해 유기층을 추출한 후 컬럼정제(N-HEXANE : MC)하여 <화합물 19> 4.2 g(수율 57%) 수득하였다.Compound 1 (6.2 g, 0.010 mol) was dissolved in 60 mL of THF, cooled to 0 ° C., and then phenyl magnesium bromide (4.5 g, 0.025 mol) was added slowly. Thereafter, the temperature was slowly raised to room temperature, and then the mixture was stirred for 12 hours to add distilled water, and the reaction was terminated. Then, the organic layer was extracted with EA and purified by column (N-HEXANE: MC) to obtain 4.2 g (yield: 57%) of Compound 19.

H-NMR (200MHz, CDCl3):δ ppm, 2H(7.26/m, 5.65/s) 4H(7.33/m, 7.11/d) 5H(6.81/m) 10H(7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (7.26 / m, 5.65 / s) 4H (7.33 / m, 7.11 / d) 5H (6.81 / m) 10H (7.20 / m, 6.63 / d)

LC/MS: m/z=744 [(M+1)+]
LC / MS: m / z = 744 [(M + 1) &lt; + &

실시예Example 20 : 화합물 20 합성 20: Compound 20 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 20-1의 합성 1: Synthesis of intermediate 20-1

Figure 112014127180143-pat00172
Figure 112014127180143-pat00172

3,5-dimethylaniline(1.2 g, 0.010 mol)에 4-bromodibenzo[b,d]furan(2.7 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 20-1> 1.9 g(수율 67%)을 얻었다. (m/z=287)
Synthesis was carried out in the same manner as in Example 1 (4) except that 4-bromodibenzo [b, d] furan (2.7 g, 0.011 mol) was added to 3,5-dimethylaniline (1.2 g, 0.010 mol) 1> 1.9 g (yield 67%). (m / z = 287)

(2) (2) 제조예Manufacturing example 2 : 중간체 20-2의 합성 2: Synthesis of intermediate 20-2

Figure 112014127180143-pat00173
Figure 112014127180143-pat00173

중간체 1-3(3.5 g, 0.010 mol)에 중간체 20-1(6.3 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 20-2> 5.2 g(수율 61%)을 얻었다. (m/z=856)
Intermediate 20-1 was obtained in a yield of 5.2 g (yield: 82%) in the same manner as in Example 1 (4) except that Intermediate 20-1 (6.3 g, 0.022 mol) 61%). (m / z = 856)

(3) (3) 제조예Manufacturing example 3 : 화합물 20의 합성 3: Synthesis of Compound 20

Figure 112014127180143-pat00174
Figure 112014127180143-pat00174

중간체 20-2(8.6 g, 0.010 mol)에 phenylmagnesium bromide(4.5 g, 0.025 mol)을 넣고 실시예 19-제조예 (1)과 동일한 방법으로 합성하여 <화합물 20> 5.4 g (수율 55%)을 얻었다.Compound (20) (5.4 g, yield 55%) was synthesized in the same manner as in PREPARATION 19- PREPARATION (1) except that phenylmagnesium bromide (4.5 g, 0.025 mol) was added to intermediate 20-2 (8.6 g, 0.010 mol) .

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(7.89/d, 7.66/d, 7.38/m, 7.32/m, 7.26/m, 7.25/d, 7.20/m, 7.07/m, 6.71/s, 6.63/d, 6.39/d, 5.87/d, 5.65/s) 4H(7.33/m, 7.11/d, 6.36/s, 2.34/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (7.89 / d, 7.66 / d, 7.38 / m, 7.32 / m, 7.26 / m, 7.25 / d, 7.20 / m, 7.07 (7.33 / m, 7.11 / d, 6.36 / s, 2.34 / s)

LC/MS: m/z=981 [(M+1)+]
LC / MS: m / z = 981 [(M + 1) &lt; + &

실시예Example 21 : 화합물 21 합성 21: Compound 21 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 15-1의 합성 1: Synthesis of intermediate 15-1

Figure 112014127180143-pat00175
Figure 112014127180143-pat00175

p-toluidine(1.1 g, 0.010 mol)에 (4-bromophenyl)trimethylsilane(2.5 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 21-1> 1.7 g (수율 65%)을 얻었다. (m/z=255)
(4-bromophenyl) trimethylsilane (2.5 g, 0.011 mol) was added to p-toluidine (1.1 g, 0.010 mol) Yield: 65%). (m / z = 255)

(2) (2) 제조예Manufacturing example 2 : 중간체 21-2의 합성 2: Synthesis of intermediate 21-2

Figure 112014127180143-pat00176
Figure 112014127180143-pat00176

중간체 6-1(9.8 g, 0.020 mol)에 중간체 21-1(5.6 g, 0.022 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <화합물 15> 2.5 g(수율 57%)을 얻었다. (m/z=430)
Synthesis was conducted in the same manner as in PREPARATION 1-PREPARATION (4) to give Intermediate 21-1 (5.6 g, 0.022 mol) and Intermediate 6-1 (9.8 g, 0.020 mol) ). (m / z = 430)

(3) (3) 제조예Manufacturing example 3 : 화합물 21의 합성 3: Synthesis of Compound 21

Figure 112014127180143-pat00177
Figure 112014127180143-pat00177

중간체 21-2(4.4 g, 0.010 mol)에 phenylmagnesium bromide(4.5 g, 0.025 mol)을 넣고 실시예 19-제조예 (1)과 동일한 방법으로 합성하여 <화합물 21> 5.9 g (수율 59%)을 얻었다.5.9 g (Yield: 59%) of Compound 21 was synthesized in the same manner as in Example 19- (1) except that phenylmagnesium bromide (4.5 g, 0.025 mol) was added to Intermediate 21-2 (4.4 g, 0.010 mol) .

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m) 2H(7.52/d, 7.51/m, 7.26/m, 6.73/d, 5.87/d, 5.65/s, 2.34/s) 4H(7.33/m, 7.15/d, 7.11/d, 6.98/d, 6.61/d, 6.51/d) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m) 2H (7.52 / d, 7.51 / m, 7.26 / m, 6.73 / d, 5.87 / d, 5.65 / s, 2.34 / s) 4H (7.33 / m, 7.15 / d, 7.11 / d, 6.98 / d, 6.61 / d, 6.51 / d)

LC/MS: m/z= 993[(M+1)+]
LC / MS: m / z = 993 [(M + 1) &lt; + &

실시예Example 22 : 화합물 22 합성 22: Compound 22 Synthesis

(1) (One) 제조예Manufacturing example 1 : 화합물 22의 합성 1: Synthesis of Compound 22

Figure 112014127180143-pat00178
Figure 112014127180143-pat00178

화합물 7(6.2 g, 0.010 mol)에 phenylmagnesium bromide(4.5 g, 0.025 mol)을 넣고 실시예 19-제조예 (1)과 동일한 방법으로 합성하여 <화합물 21> 3.5 g (수율 47%)을 얻었다.Compound 21 was obtained in an amount of 3.5 g (yield: 47%) by the same method as in PREPARATION 19-PREPARATION (1) except that phenylmagnesium bromide (4.5 g, 0.025 mol) was added to compound 7 (6.2 g, 0.010 mol).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(8.55/d, 8.12/d, 7.94/d, 7.63/d, 7.50/m, 7.33/m, 7.29/m, 7.26/m, 7.25/m, 7.20/m, 6.98/d, 6.63/d, 6.60/d, 6.30/s) 4H(7.33/m, 7.11/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (8.55 / d, 8.12 / d, 7.94 / d, 7.63 / d, 7.50 / m, 7.33 / m, 7.29 / m, 7.26 d), 6.30 (d), 6.30 (d), 6.30 (d, 6H)

LC/MS: m/z= 740[(M+1)+]
LC / MS: m / z = 740 [(M + 1) &lt; + &

실시예Example 23 : 화합물 23 합성 23: Compound 23 Synthesis

(1) (One) 제조예Manufacturing example 1 : 중간체 23-1의 합성 1: Synthesis of intermediate 23-1

Figure 112014127180143-pat00179
Figure 112014127180143-pat00179

4-(trimethylsilyl)aniline(1.7 g, 0.010 mol)에 중간체 11-2(3.9 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 17-1> 1.9 g (수율 51%)을 얻었다. (m/z=367)
Intermediate 11-1 (3.9 g, 0.011 mol) was added to 4- (trimethylsilyl) aniline (1.7 g, 0.010 mol) (Yield: 51%). (m / z = 367)

(2) (2) 제조예Manufacturing example 2 : 중간체 23-2의 합성 2: Synthesis of intermediate 23-2

Figure 112014127180143-pat00180
Figure 112014127180143-pat00180

중간체 23-1(3.7 g, 0.010 mol)에 1,4-dibromobenzene(2.7 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 23-2> 2.8 g(수율 54%)을 얻었다. (m/z=522)
(2.7 g, 0.011 mol) was added to Intermediate 23-1 (3.7 g, 0.010 mol) in the same manner as in Example 1 (4) to give 2.8 g of Intermediate 23-2 Yield: 54%). (m / z = 522)

(3) (3) 제조예Manufacturing example 3 : 중간체 23-3의 합성 3: Synthesis of intermediate 23-3

Figure 112014127180143-pat00181
Figure 112014127180143-pat00181

중간체 14-1(3.6 g, 0.010 mol)에 중간체 23-2(5.7 g, 0.011 mol)을 넣고 실시예 1-제조예 (4)와 동일한 방법으로 합성하여 <중간체 23-3> 4.6 g(수율 57%)을 얻었다. (m/z=803)
Intermediate 23-2 (5.7 g, 0.011 mol) was added to Intermediate 14-1 (3.6 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (4) 57%). (m / z = 803)

(4) (4) 제조예Manufacturing example 4 : 화합물 23의 합성 4: Synthesis of Compound 23

Figure 112014127180143-pat00182
Figure 112014127180143-pat00182

중간체 23-3(8.0 g, 0.010 mol)에 phenylmagnesium bromide(4.5 g, 0.025 mol)을 넣고 실시예 19-제조예 (1)과 동일한 방법으로 합성하여 <화합물 23> 5.2 g (수율 56%)을 얻었다.5.2 g (yield: 56%) of compound 23 was synthesized in the same manner as in PREPARATION 19- PREPARATION EXAMPLE 1, except that phenylmagnesium bromide (4.5 g, 0.025 mol) was added to Intermediate 23-3 (8.0 g, 0.010 mol) .

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.43/d, 7.85/d, 7.46/m, 7.32/m, 6.99/s, 6.76/s) 2H(7.79/d, 7.26/m, 7.15/d, 6.77/s, 6.69/d, 6.61/d) 3H(7.41/m, 0.25/s) 4H(7.52/d, 7.33/m, 7.11/d, 6.38/d) 6H(7.51/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.43 / d, 7.85 / d, 7.46 / m, 7.32 / m, 6.99 / s, 6.76 / s) 2H (7.79 / d, 7.26 / m, 7.15 6H (7.51 / m), 6H (7.41 / m, 0.25 / s), 4H (7.52 / d, 7.33 / m, 7.11 / d, 6.38 / d)

LC/MS: m/z=928 [(M+1)+]
LC / MS: m / z = 928 [(M + 1) &lt; + &

소자 device 실시예Example 1 : 화합물 4를  1: Compound 4 발광층의The light- 형광  Neon 블루blue 도펀트Dopant 재료로 채용한  Used as a material 유기abandonment 전계발광소자의 제조Fabrication of electroluminescent device

ITO 투명전극 (양극)을 isopropyl-Alcohol에서 초음파 세정을 5분간 실시한 후, UV오존 세정을 30분간 실시하였다. 세정 후의 투명전극라인이 형성된 유리 기판을 진공증착 장치의 기판 홀더에 장착하고, 먼저 투명 전극 라인이 형성되어 있는 측면 상에 투명전극을 덮도록 정공주입재료로 CuPc(30 nm)을 증착하였다. 그 위에 정공수송재료로 NPB(80 nm)를 증착한 후 <화합물 A> : <화합물 4>을 20:1의 질량비로 증착하여 막 두께 30 nm로 발광층을 형성하였다. 그 후 전자주입재료로 Alq3(5 nm), LiF(1 nm)를 형성한 후, Al(80 nm)로 음극을 형성하였다.
The ITO transparent electrode (anode) was subjected to ultrasonic cleaning for 5 minutes in isopropyl-alcohol, followed by UV ozone cleaning for 30 minutes. A glass substrate on which a transparent electrode line after cleaning was formed was mounted on a substrate holder of a vacuum evaporation apparatus. First, CuPc (30 nm) was deposited as a hole injecting material on the side where the transparent electrode line was formed to cover the transparent electrode. NPB (80 nm) was deposited thereon as a hole transporting material, and then Compound A: Compound 4 was deposited at a mass ratio of 20: 1 to form a light emitting layer having a thickness of 30 nm. After that, Alq3 (5 nm) and LiF (1 nm) were formed as an electron injecting material, and a negative electrode was formed with Al (80 nm).

소자 device 실시예Example 2 내지 13 2 to 13

상기 화합물 4 대신 하기 [표 1]에 기재된 화합물을 사용한 것을 제외하고는 소자 실시예 1과 동일한 방법으로 소자 실시예 2 내지 13의 유기전계발광소자를 제조하였다.
Organic electroluminescent devices of Device Examples 2 to 13 were fabricated in the same manner as in Example 1 except that the compound described in [Table 1] was used in place of the compound 4 described above.

소자 device 비교예Comparative Example 1 One

비교예 1를 위한 유기전계발광소자는 상기 실시예의 소자구조에서 발명에 의해 제조된 화합물 대신 일반적으로 형광 도펀트 물질로 많이 사용되고 있는 화합물B를 사용한 점을 제외하고 동일하게 제작하였다.
The organic electroluminescent device for Comparative Example 1 was fabricated in the same manner except that Compound B, which is generally used as a fluorescent dopant material, was used in place of the compound prepared by the invention in the device structure of the embodiment.

소자 device 실시예Example 14 : 화합물 1을  14: Compound 1 전자층을The electronic layer 차단하는  Blocking 정공수송재료로With hole transport material 채용한  Employed U 기전계발광소자의 제조Manufacture of electro-optical optical devices

ITO 투명전극 (양극)을 isopropyl-Alcohol에서 초음파 세정을 5분간 실시한 후, UV오존 세정을 30분간 실시하였다. 세정 후의 투명전극라인이 형성된 유리 기판을 진공증착 장치의 기판 홀더에 장착하고, 먼저 투명 전극 라인이 형성되어 있는 측면 상에 투명전극을 덮도록 정공주입재료로 HATCN(5 nm)을 증착하였다. 그 위에 정공수송재료로 NPB(100 nm)를 증착한 후, 전자가 정공수송층으로 쉽게 흐르는 것을 차단할 수 있는 <화합물 1>(10 nm)를 증착하였다. 그리고, CBP : Ir(ppy)3를 20:1의 질량비로 증착하여 막 두께 30 nm로 발광층을 형성하였다. 그 후 전자주입재료로 Alq3(5 nm), LiF(1 nm)를 형성한 후, Al(80 nm)로 음극을 형성하였다.
The ITO transparent electrode (anode) was subjected to ultrasonic cleaning for 5 minutes in isopropyl-alcohol, followed by UV ozone cleaning for 30 minutes. The cleaned glass substrate on which the transparent electrode line was formed was mounted on the substrate holder of the vacuum evaporation apparatus. HATCN (5 nm) was deposited as a hole injecting material on the side where the transparent electrode line was formed first. NPB (100 nm) was deposited thereon as a hole transporting material, and Compound 1 (10 nm) was deposited to prevent electrons from easily flowing into the hole transporting layer. Then, CBP: Ir (ppy) 3 was vapor-deposited at a mass ratio of 20: 1 to form a light emitting layer with a film thickness of 30 nm. After that, Alq3 (5 nm) and LiF (1 nm) were formed as an electron injecting material, and a negative electrode was formed with Al (80 nm).

소자 device 실시예Example 15 내지 18 15 to 18

상기 화합물 1 대신 하기 [표 2]에 기재된 화합물을 사용한 것을 제외하고는 소자 실시예 14와 동일한 방법으로 소자 실시예 15 내지 18의 유기전계발광소자를 제조하였다.
An organic electroluminescent device of each of the device embodiments 15 to 18 was fabricated in the same manner as in the device example 14, except that the compound described in [Table 2] was used instead of the compound 1 described above.

소자 device 비교예Comparative Example 2 2

비교예 2를 위한 유기전계발광소자는 상기 실시예 14 내지 18의 소자구조에서 발명에 의해 제조된 화합물 대신 일반적으로 전자차단층으로 많이 사용되고 있는 TCTA를 사용한 점을 제외하고 동일하게 제작하였다.
The organic electroluminescent device for Comparative Example 2 was fabricated in the same manner as the devices of Examples 14 to 18, except that TCTA, which is generally used as an electron blocking layer instead of the compound prepared by the present invention, was used.

소자 device 실시예Example 19 내지 23 19 to 23

상기 도펀트 Ir(ppy)3 대신 Ir(btp)2(acac)를 사용한 것을 제외하고는 소자실시예 18과 동일한 방법으로 소자 실시예 19 내지 23의 유기전계발광소자를 제조하였다.
An organic electroluminescent device of each of the device embodiments 19 to 23 was fabricated in the same manner as in the device example 18 except that Ir (btp) 2 (acac) was used instead of the dopant Ir (ppy) 3.

소자 device 비교예Comparative Example 3 3

비교예 3을 위한 유기전계발광소자는 상기 실시예 19 내지 23의 소자구조에서 발명에 의해 제조된 화합물 대신 일반적으로 전자차단층으로 많이 사용되고 있는 TCTA를 사용한 점을 제외하고 동일하게 제작하였다.The organic electroluminescent device for Comparative Example 3 was fabricated in the same manner as the devices of Examples 19 to 23, except that TCTA, which is generally used as an electron blocking layer instead of the compound prepared by the invention, was used.

상기에서 사용된 화합물의 구조는 다음과 같다.The structure of the compound used above is as follows.

Figure 112014127180143-pat00183

Figure 112014127180143-pat00183

이하, 상기 소자 실시예 1 내지 13과 소자 비교예 1, 2, 3에 따라 제조된 유기 전계 발광소자의 특성을 비교한 결과를 하기 [표 1], [표 2]에 나타내었다.Hereinafter, the characteristics of the organic electroluminescent devices manufactured according to the device embodiments 1 to 13 and the device comparison examples 1, 2, and 3 are compared, and the results are shown in [Table 1] and [Table 2] below.

[표 1][Table 1]

Figure 112014127180143-pat00184

Figure 112014127180143-pat00184

[표 2][Table 2]

Figure 112014127180143-pat00185

Figure 112014127180143-pat00185

구동전압 및 발광효율 측정Measurement of driving voltage and luminous efficiency

상기 실시예 및 비교예에 따른 유기전계발광소자(기판크기 : 25 × 25 ㎟/증착면적 : 2 × 2 ㎟)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정한 후 전류를 1 mA/㎡씩 상승시키며 증착면의 발광 휘도(cd/㎡), 구동전압(V), 발광효율(cd/A)을 측정하여 상기 [표 1], [표 2]에 나타내었다.After fixing the organic electroluminescent device (substrate size: 25 × 25 mm 2 / deposition area: 2 × 2 mm 2) according to the above Examples and Comparative Examples to an IVL measurement set (CS-2000 + jig + IVL program) (Cd / m &lt; 2 &gt;), driving voltage (V) and luminous efficiency (cd / A) of the deposition surface were measured. The results are shown in Table 1 and Table 2, respectively.

상기 실시예와 비교예 및 [표 1] 및 [표 2]의 결과로부터, 본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물을 채용한 소자는 종래의 청색형광발광재료, 전자차단층 재료를 채용한 소자에 비하여 구동전압 및 발광효율 등의 특성이 우수하여, 표시소자, 디스플레이 소자 및 조명 등에 유용하게 사용될 수 있음을 알 수 있다.From the results of the above Examples and Comparative Examples and [Table 1] and [Table 2], the device employing the organic luminescent compound represented by the formula (1) according to the present invention is a conventional blue luminescent material, The characteristics such as the driving voltage and the luminous efficiency are superior to those of the device employing the light emitting device and can be used effectively for display devices, display devices, lighting, and the like.

Claims (10)

하기 [화학식 1]로 표시되는 유기발광 화합물:
[화학식 1]
Figure 112017124038202-pat00186

상기 [화학식 1]에서,
X는 R1-C-R2이고, 상기 R1 및 R2는 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 7의 알킬기 및 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 중에서 선택되고,
A는 하기 [구조식 1] 또는 [구조식 2]로 표시되고,
[구조식 1]
Figure 112017124038202-pat00187

[구조식 2]
Figure 112017124038202-pat00188

상기 [구조식 1] 또는 [구조식 2]에서,
L은 직접결합이거나, 치환 또는 비치환된 탄소수 6 내지 20의 시클로알킬렌기, 치환 또는 비치환된 탄소수 6 내지 20의 아릴렌기 및 치환 또는 비치환된 탄소수 3 내지 30의 헤테로아릴렌기 중에서 선택되고, n은 0 내지 2의 정수이며, 상기 n이 2인 경우, 복수 개의 L은 서로 동일하거나 상이하고,
Ar1 내지 Ar7은 서로 동일하거나 상이하고, 각각 치환 또는 비치환된 탄소수 6 내지 20의 시클로알킬기, 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 헤테로아릴기 중에서 선택되며,
상기 Ar1과 Ar2, Ar3와 Ar4 및 Ar5와 Ar6는 서로 결합하거나 인접한 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S 및 O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있고,
p는 1 내지 2의 정수이고, 상기 p가 2인 경우 복수의 *-( )는 서로 동일하거나 상이할 수 있다.
An organic light-emitting compound represented by the following Formula 1:
[Chemical Formula 1]
Figure 112017124038202-pat00186

In the above formula (1)
X is R 1 -CR 2 , wherein R 1 and R 2 are each independently selected from a substituted or unsubstituted alkyl group having 1 to 7 carbon atoms and a substituted or unsubstituted aryl group having 6 to 20 carbon atoms,
A is represented by [Structural Formula 1] or [Structural Formula 2] below,
[Structural formula 1]
Figure 112017124038202-pat00187

[Structural formula 2]
Figure 112017124038202-pat00188

In the structural formula 1 or the structural formula 2,
L is a direct bond, a substituted or unsubstituted C6-C20 A substituted or unsubstituted arylene group having 6 to 20 carbon atoms and a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms, n is an integer of 0 to 2, and when n is 2, A plurality of L's may be the same or different from each other,
Ar 1 to Ar 7 are the same or different and each represents a substituted or unsubstituted cycloalkyl group having 6 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, and a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms An aryl group,
Ar 1 and Ar 2 , Ar 3 and Ar 4, and Ar 5 and Ar 6 may be bonded to each other or may be connected to adjacent substituents to form a single alicyclic or aromatic ring or polycyclic ring, and the alicyclic or aromatic The carbon atom of the monocyclic or polycyclic ring may be substituted with any one or more heteroatoms selected from N, S and O,
p is an integer of 1 to 2, and when p is 2, a plurality of * - () may be the same or different from each other.
제1항에 있어서,
상기 R1, R2, L 및 Ar1 내지 Ar7은 1종 이상의 치환기로 더 치환될 수 있고, 상기 1종 이상의 치환기는 수소, 중수소, 시아노기, 할로겐기, 아미노기, 탄소수 1 내지 7의 알킬기, 탄소수 1 내지 7의 할로겐화된 알킬기, 탄소수 6 내지 20의 아릴기, 탄소수 3 내지 30의 헤테로아릴기 및 탄소수 1 내지 7의 알킬실릴기 중에서 선택되는 것을 특징으로 하는 유기발광 화합물.
The method according to claim 1,
R 1 , R 2 , L and Ar 1 to Ar 7 may be further substituted with one or more substituents, and the one or more substituents may be selected from the group consisting of hydrogen, deuterium, cyano, halogen, amino, , A halogenated alkyl group having 1 to 7 carbon atoms, an aryl group having 6 to 20 carbon atoms, a heteroaryl group having 3 to 30 carbon atoms, and an alkylsilyl group having 1 to 7 carbon atoms.
제1항에 있어서,
상기 [화학식 1]은 하기 화합물 중에서 선택되는 것을 특징으로 하는 유기발광 화합물:
Figure 112017124038202-pat00305

Figure 112017124038202-pat00306

Figure 112017124038202-pat00307

Figure 112017124038202-pat00192

Figure 112017124038202-pat00193

Figure 112017124038202-pat00194

Figure 112017124038202-pat00195

Figure 112017124038202-pat00196

Figure 112017124038202-pat00197

Figure 112017124038202-pat00198

Figure 112017124038202-pat00199

Figure 112017124038202-pat00200

Figure 112017124038202-pat00201

Figure 112017124038202-pat00202

Figure 112017124038202-pat00203

Figure 112017124038202-pat00204

Figure 112017124038202-pat00205

Figure 112017124038202-pat00206

Figure 112017124038202-pat00207

Figure 112017124038202-pat00208

Figure 112017124038202-pat00209

Figure 112017124038202-pat00210

Figure 112017124038202-pat00308

Figure 112017124038202-pat00309

Figure 112017124038202-pat00310

Figure 112017124038202-pat00311

Figure 112017124038202-pat00213

Figure 112017124038202-pat00214

Figure 112017124038202-pat00215

Figure 112017124038202-pat00216

Figure 112017124038202-pat00217

Figure 112017124038202-pat00218

Figure 112017124038202-pat00312

Figure 112017124038202-pat00313

Figure 112017124038202-pat00220

Figure 112017124038202-pat00314

Figure 112017124038202-pat00315

Figure 112017124038202-pat00316

Figure 112017124038202-pat00317

Figure 112017124038202-pat00228

Figure 112017124038202-pat00229

Figure 112017124038202-pat00230

Figure 112017124038202-pat00231

Figure 112017124038202-pat00232

Figure 112017124038202-pat00318

Figure 112017124038202-pat00319

Figure 112017124038202-pat00320

Figure 112017124038202-pat00235

Figure 112017124038202-pat00236

Figure 112017124038202-pat00237

Figure 112017124038202-pat00238

Figure 112017124038202-pat00239

Figure 112017124038202-pat00240

Figure 112017124038202-pat00241

Figure 112017124038202-pat00242

Figure 112017124038202-pat00243

Figure 112017124038202-pat00244

Figure 112017124038202-pat00245

Figure 112017124038202-pat00246

Figure 112017124038202-pat00247

Figure 112017124038202-pat00248

Figure 112017124038202-pat00249

Figure 112017124038202-pat00250

Figure 112017124038202-pat00251

Figure 112017124038202-pat00252

Figure 112017124038202-pat00253

Figure 112017124038202-pat00254

Figure 112017124038202-pat00255

Figure 112017124038202-pat00256

Figure 112017124038202-pat00257

Figure 112017124038202-pat00258

Figure 112017124038202-pat00259

Figure 112017124038202-pat00260

Figure 112017124038202-pat00261

Figure 112017124038202-pat00262

Figure 112017124038202-pat00263

Figure 112017124038202-pat00264

Figure 112017124038202-pat00265

Figure 112017124038202-pat00266

Figure 112017124038202-pat00321

Figure 112017124038202-pat00322

Figure 112017124038202-pat00276

Figure 112017124038202-pat00277

Figure 112017124038202-pat00278

Figure 112017124038202-pat00279

Figure 112017124038202-pat00323

Figure 112017124038202-pat00281

Figure 112017124038202-pat00282

Figure 112017124038202-pat00283
The method according to claim 1,
The organic luminescent compound according to claim 1, wherein the compound represented by Formula 1 is selected from the following compounds:
Figure 112017124038202-pat00305

Figure 112017124038202-pat00306

Figure 112017124038202-pat00307

Figure 112017124038202-pat00192

Figure 112017124038202-pat00193

Figure 112017124038202-pat00194

Figure 112017124038202-pat00195

Figure 112017124038202-pat00196

Figure 112017124038202-pat00197

Figure 112017124038202-pat00198

Figure 112017124038202-pat00199

Figure 112017124038202-pat00200

Figure 112017124038202-pat00201

Figure 112017124038202-pat00202

Figure 112017124038202-pat00203

Figure 112017124038202-pat00204

Figure 112017124038202-pat00205

Figure 112017124038202-pat00206

Figure 112017124038202-pat00207

Figure 112017124038202-pat00208

Figure 112017124038202-pat00209

Figure 112017124038202-pat00210

Figure 112017124038202-pat00308

Figure 112017124038202-pat00309

Figure 112017124038202-pat00310

Figure 112017124038202-pat00311

Figure 112017124038202-pat00213

Figure 112017124038202-pat00214

Figure 112017124038202-pat00215

Figure 112017124038202-pat00216

Figure 112017124038202-pat00217

Figure 112017124038202-pat00218

Figure 112017124038202-pat00312

Figure 112017124038202-pat00313

Figure 112017124038202-pat00220

Figure 112017124038202-pat00314

Figure 112017124038202-pat00315

Figure 112017124038202-pat00316

Figure 112017124038202-pat00317

Figure 112017124038202-pat00228

Figure 112017124038202-pat00229

Figure 112017124038202-pat00230

Figure 112017124038202-pat00231

Figure 112017124038202-pat00232

Figure 112017124038202-pat00318

Figure 112017124038202-pat00319

Figure 112017124038202-pat00320

Figure 112017124038202-pat00235

Figure 112017124038202-pat00236

Figure 112017124038202-pat00237

Figure 112017124038202-pat00238

Figure 112017124038202-pat00239

Figure 112017124038202-pat00240

Figure 112017124038202-pat00241

Figure 112017124038202-pat00242

Figure 112017124038202-pat00243

Figure 112017124038202-pat00244

Figure 112017124038202-pat00245

Figure 112017124038202-pat00246

Figure 112017124038202-pat00247

Figure 112017124038202-pat00248

Figure 112017124038202-pat00249

Figure 112017124038202-pat00250

Figure 112017124038202-pat00251

Figure 112017124038202-pat00252

Figure 112017124038202-pat00253

Figure 112017124038202-pat00254

Figure 112017124038202-pat00255

Figure 112017124038202-pat00256

Figure 112017124038202-pat00257

Figure 112017124038202-pat00258

Figure 112017124038202-pat00259

Figure 112017124038202-pat00260

Figure 112017124038202-pat00261

Figure 112017124038202-pat00262

Figure 112017124038202-pat00263

Figure 112017124038202-pat00264

Figure 112017124038202-pat00265

Figure 112017124038202-pat00266

Figure 112017124038202-pat00321

Figure 112017124038202-pat00322

Figure 112017124038202-pat00276

Figure 112017124038202-pat00277

Figure 112017124038202-pat00278

Figure 112017124038202-pat00279

Figure 112017124038202-pat00323

Figure 112017124038202-pat00281

Figure 112017124038202-pat00282

Figure 112017124038202-pat00283
제1 전극, 제2 전극, 및 상기 제1 전극과 제2 전극 사이에 배치된 1층 이상의 유기물층을 포함하는 유기전계발광소자로서,
상기 유기물층 중 1 층 이상은 제1항에 따른 [화학식 1]의 유기발광 화합물을 포함하는 것인 유기전계발광소자.
1. An organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic material layer disposed between the first electrode and the second electrode,
Wherein at least one of the organic material layers comprises an organic light emitting compound represented by Formula 1 according to Claim 1.
제4항에 있어서,
상기 유기물층은 정공 주입층, 정공 수송층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 수송층, 전자 주입층, 전자 수송 및 전자 주입을 동시에 하는 층 및 발광층 중 1층 이상을 포함하고,
상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
5. The method of claim 4,
Wherein the organic material layer includes at least one of a hole injecting layer, a hole transporting layer, a layer simultaneously transporting holes and holes, an electron transporting layer, an electron injecting layer, a layer that simultaneously transports electrons and electrons,
Wherein at least one of the layers comprises an organic light-emitting compound represented by the formula (1).
제5항에 있어서,
상기 발광층이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
6. The method of claim 5,
Wherein the light emitting layer comprises an organic light emitting compound represented by the following formula (1).
제6항에 있어서,
상기 [화학식 1]로 표시되는 유기발광 화합물은 상기 발광층 내의 도판트 화합물로 사용되는 것을 특징으로 하는 유기전계발광소자.
The method according to claim 6,
Wherein the organic light emitting compound represented by Formula 1 is used as a dopant compound in the light emitting layer.
제7항에 있어서,
상기 발광층은 [화학식 1]로 표시되는 유기발광 화합물 외의 도판트 화합물과 호스트 화합물을 1종 이상 더 포함하는 것을 특징으로 하는 유기전계발광소자.
8. The method of claim 7,
Wherein the light emitting layer further comprises at least one dopant compound other than the organic light emitting compound represented by Formula 1 and a host compound.
제5항에 있어서,
상기 정공 수송층 또는 정공 주입 및 정공 수송을 동시에 하는 층이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
6. The method of claim 5,
Wherein the hole transport layer or the layer simultaneously injecting holes and transporting holes comprises an organic light emitting compound represented by the following formula (1).
삭제delete
KR1020140192183A 2014-12-29 2014-12-29 An electroluminescent compound and an electroluminescent device comprising the same KR101852926B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140192183A KR101852926B1 (en) 2014-12-29 2014-12-29 An electroluminescent compound and an electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140192183A KR101852926B1 (en) 2014-12-29 2014-12-29 An electroluminescent compound and an electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20160080420A KR20160080420A (en) 2016-07-08
KR101852926B1 true KR101852926B1 (en) 2018-04-27

Family

ID=56502819

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140192183A KR101852926B1 (en) 2014-12-29 2014-12-29 An electroluminescent compound and an electroluminescent device comprising the same

Country Status (1)

Country Link
KR (1) KR101852926B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11289657B2 (en) * 2018-03-26 2022-03-29 Samsung Display Co., Ltd. Heterocyclic compound and organic light-emitting device including the same

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107765510B (en) * 2016-08-16 2020-02-07 常州强力电子新材料股份有限公司 9-phenylacridine macromolecular photosensitizer and preparation method and application thereof
WO2018092927A1 (en) * 2016-11-16 2018-05-24 주식회사 진웅산업 Carbazole compound and organic light-emitting element comprising same
CN108203429A (en) * 2016-12-20 2018-06-26 江苏三月光电科技有限公司 Using the nitrogenous hexa-member heterocycle of dibenzo as the compound and organic electroluminescence device of core
KR101954366B1 (en) * 2016-12-23 2019-03-05 주식회사 진웅산업 Pyrimidine compound and organic light emitting element comprising the same
CN106831743B (en) 2016-12-30 2020-03-17 上海天马有机发光显示技术有限公司 Organic electroluminescent material and organic photoelectric device
CN106831633B (en) * 2016-12-30 2019-05-28 上海天马有机发光显示技术有限公司 A kind of electroluminescent organic material and organic photoelectric device
KR102450436B1 (en) * 2017-08-01 2022-10-04 삼성디스플레이 주식회사 Heterocyclic compound and organic electroluminescence device including the same
KR102515592B1 (en) * 2017-08-24 2023-03-30 삼성디스플레이 주식회사 Compound including nitrogen and organic electroluminescence device including the same
KR20190052505A (en) * 2017-11-08 2019-05-16 에스에프씨 주식회사 Naphthalene derivatives having substituted amine groups and organic light-emitting diode including the same
KR102087487B1 (en) * 2017-11-30 2020-03-10 주식회사 엘지화학 New compound and organic light emitting device comprising the same
CN108299295A (en) * 2018-02-07 2018-07-20 瑞声科技(南京)有限公司 A kind of organic photoelectrical material and organic light emitting diode device
CN109734608B (en) * 2018-11-29 2022-04-08 宇瑞(上海)化学有限公司 Organic compound and organic electroluminescent device using same
CN109912505A (en) * 2019-04-16 2019-06-21 武汉华星光电半导体显示技术有限公司 Thermal activation delayed fluorescence material and preparation method thereof and organic electroluminescent diode apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11289657B2 (en) * 2018-03-26 2022-03-29 Samsung Display Co., Ltd. Heterocyclic compound and organic light-emitting device including the same

Also Published As

Publication number Publication date
KR20160080420A (en) 2016-07-08

Similar Documents

Publication Publication Date Title
KR101852926B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101825405B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101530266B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627691B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20170082459A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101842013B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101626524B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160127429A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101837048B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101790550B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160066308A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101713530B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20150110101A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627695B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101666826B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101597865B1 (en) New compounds and organic electronic device using the same
KR20160054870A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20150133097A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101838504B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR102316570B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627693B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101638073B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101816810B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20180042967A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101891714B1 (en) An electroluminescent compound and an electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant